Altech Chemicals Capital Raising Update July 2016

22nd July 2016, ASX Announcement

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) advises that further to the suspension in trading of the Company’s securities on the Australian Securities Exchange (ASX) pre-open this morning, Perth stockbroking firm DJ Carmichael Pty Ltd (Lead Manager) and Hong Kong stockbroking firm Empire Capital Partners (Co-Manager) are arranging a placement of fully paid ordinary shares of the Company to a variety of professional and sophisticated investors (the Placement).

Funds raised by the Placement will be applied to the detailed design of the Company’s proposed high purity alumina (HPA) plant at Johor, Malaysia, the completion of debt financing for the project and for general working capital purposes.

To view the full announcement, please click on the button below.

MyWave FY16 Update: Best Enabling Technology Award, UK Expansion, In Third Successful Capital Round

MyWave is in its third successful capital round and invites further interest. We have received a Best Enabling Technology Award for Customer Experience from Independent Analyst Firm Frost & Sullivan,  are live in market with our Intelligent Automated Energy Switching service and now expanding that into the UK with very attractive revenue metrics.  Peter Diamandis author of Bold, Abundance and Singularity University has agreed to become an Advisor to MyWave and we are delighted to be working with Peter advancing exponential growth and the positive disruption of key industries globally.  We are enhancing customer experience and enabling the Fourth Industrial Revolution with MyWave’s unique and world leading Intelligent Assistant that combines machine learning, personal data and commerce.

ABOUT MYWAVE 

MyWave is a thought leading technology company re-imagining the future of digital relationships between businesses and consumers.

Founded by Geraldine McBride, former President of SAP North America, MyWave flips the traditional Customer Relationship Management (CRM) model on its head by putting the customer in control of their data via a Virtual Personal Assistant (VPA) called Frank®. Frank personalises the consumer/brand relationship, making life easier by connecting people in a frictionless, relevant and customer outcome-focused manner.

MyWave is enjoying strong market momentum within the banking, tourism, retail, utilities and automotive sectors, described as ‘revolutionary’ and ‘an enabler of new digital customer centric business models’.

Martin Aircraft Company Teams Up with Oakley and Bubba Watson to Design Golf Cart Jetpack

Ferrying your golf bags and equipment around the golf course has taken on a whole new dimension as the world’s first flying golf cart takes to the skies. The Golf Cart Jetpack is the result of a collaboration between Axstra past client Martin Aircraft Company, maker of the Martin Jetpack, sporting equipment manufacturer, Oakley, and pro golfer Bubba Watson.

Bubba Watson, two time Masters champion and currently fifth ranked golfer in the world, is known for pushing the boundaries of his sport in an attempt to make it faster and more fun. Three years ago he teamed up with Oakley to create the world’s first hovercraft golf cart. With golf returning to the Olympics this year after an absence of more than a century, Bubba and Oakley wanted to take this idea to the next level and approached Martin Aircraft Company to develop the concept based on its current pre-production prototypes. The outcome of this venture can be seen in the Bubba’s Jetpack video below.

Universal Biosensors H1 2016 Results, Presentation and Audio Presentation

21st July 2016, ASX Announcement

Highlights:

  • Total revenue of $10.5 million in 1H16, up 41% on1H15
  • Revenue from Quarterly Service Fees – generated by sales of glucose test strips – $10.3 million, up 58% on 1H15
  • Net loss of $1.2 million, improvement from 1H15 net loss of $4.1 million and trending towards breakeven
  • R&D expenditure $7.9, down 20% on 1H15 due to refocus of product development pipeline and containing costs
  • Cash balance of $13.2 million, up from $10.7 million

Universal Biosensors (ASX:UBI) today released its financial results for the first half of 2016.

To view the full announcement, please click on the button below.

To view the Presentation, please click on the button below.

To view the Audio Presentation, please click on the button below.

Flying Golf Cart Keeps Jetpack Dream Alive

20th July 2016, NZ Herald By Christopher Adams

The Martin Jetpack’s potential to become an airborne golf cart is helping keep founder Glenn Martin’s dreams for flying machine alive, says the aircraft maker’s chief executive.

The Christchurch-based Martin Aircraft Company has teamed up with sunglasses manufacturer Oakley and world number five golfer Bubba Watson to market the golfing applications of the New Zealand-developed jetpack.

A two minute YouTube video shows Watson talking-up the machine amid scenic clips of it flying above a South Island golf course.

The jetpack maker has been more focused in recent years on the professional “first responder” applications such as search and rescue and fire fighting.

That was one of the reasons for Glenn Martin’s sudden resignation from the firm’s board last year, just three months after its listing on the Australian stock exchange.

To view the full article, please click on the button below.

Leaf Resources Signs Joint Venture to Develop Five Projects

20th July 2016, ASX Announcement

Highlights

  • Leaf Resources Ltd enters into binding agreemnts with Claeris, LLC of Dallas, Texas USAto establish a joint venture entity, Leaf Development, LLC
  • Leaf Development, LLC was formed to develop up to five renewable chemical projects utilising Leaf Resources’ proprietary Glycell™ process
  • Claeris has a proven track record of developing large-scale, financially successful renewable projects
  • Claeris will invest USD$500,00 in Leaf Resources
  • The Directors of Leaf Resources believe that the agreement with Claeris will:
    - Lower transaction execution risk given Claeris’ strong track record of sourcing funding, and building large-scale commercial renewable projects;
    - Accelerate the speed of project development;
    - Facilitate more favourable commercial terms for projects;
    - Increase the field of opportunity for the deployment of Leaf Resources’ technology.

Leaf Resources Ltd (ASX: LER, “Leaf” or “Leaf Resources”) is pleased to announce the signing of binding legal agreements with US-based project developer  Claeris, LLC (“Claeris”), to establish a joint venture (JV) entity, Leaf Development, LLC (“Leaf Development”), for the purpose of developing up to five renewable chemical projects that utilise Leaf Resources’ proprietary Glycell™ process.

To view the full announcement, please click on the button below.

Crowd Mobile June Quarter Trading Update; Record Revenue Month, Tenth Consecutive Quarter of Growth

19th June 2016, ASX Announcement

Highlights for the June Quarter 

  • Tenth consecutive quarter of growth in total billed messages from the Question & Answer (“Q&A”) division with a 12% increase over the previous quarter to 2.6 million messages.
  • Q&A division growing strongly in all key metrics with Jun-16 a record revenue month and further opportunities for growth in FY17.
  • Net Debt at 30 June 2016 of $14.8 million, a reduction of $3.7 million since December.
  • Unfavourable exchange rates impact on results with quarterly revenue increasing slightly over the previous quarter to $11.54m from $11.46m and underlying EBITDA down 90% to $2.93m.
  • Payment of second Track Vendor Earn Out of EUR2.5 million ($3.7million)
  • Continued strong generation of operating cash flows on a month-to-month basis in line with expectations
  • Commercial launch of the Company’s most successful Mobile App to date ranked #1 in its category across numerous countries.

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3, Crowd Mobile, “the Company”) is pleased to report its unaudited quarterly results for the three months to 30 June, 2016, as its Q&A business continues to gain momentum and revenues continue to grow despite a number of headwinds.

To view the full announcement, please click on the button below.

Actinogen has US Patent Granted and Further Extends Xanamem Protection

20th July 2016, ASX Announcement

  • United States Patent granted for use of Xanamem™ in Alzheimer’s dementia and other diseases.
  • Xanamem™’s long patent life now further extended to 2031 in the US.
  • Comprehensive protection over Xanamem™ now received for most major markets.

Actinogen Medical Limited (Actinogen  Medical, ASX: ACW), is pleased to announce it has received official notification to grant from the United States Patent Office for the most comprehensive patent for Xanamem. This patent further extends the comprehensive cover for Xanamem through to 2031.

The patent ( US 9,365,654 B2) protects use of Xanamem™ for use in Alzheimer’s dementia and other relate diseases associated with the inhibition of the 11-beta-hydroxysteroid dehydrogenase (11β-HSD1) enzyme. Importantly this patent cover through to 2031 comes on top of previous approvals in most other major markets, including all European countries and the UK, Australia, Japan and China.

To view the full announcement, please click on the button below.

Bubba Watson Trials Golfing Jetpack in New Zealand

20th July 2016, Stuff NZ

American golfer Bubba Watson has taken to the skies, trialling a specialised jetpack in New Zealand.

The world No 5 teamed with sponsor Oakley for a novel way to get him around the course as he literally flew over the Methven Golf Club in the South Island.

“For the first time in 112 years, golf is part of the Olympics. That’s a big deal,” Watson, who is always up for a challenge, said in a promotional video for the flying golf cart.

To view the full article, please click on the button below.

Gray Line Coaches and NG1 TechFlo to be Allied Partners; US Department of Energy Grant Application Report

1. Sun Strategies Australia Announcement Regarding Gray Line Coaches and NG1 TechFlo

Ed Manners, Chairman and CEO of the Sun Strategies Group, an investor in NG1 Technologies Inc and their Deputy Chairman advises that Gray Line Worldwide, the world’s largest provider of sightseeing tours, had selected cleantech innovator NG1 Technologies as an Allied Partner to bring TechFlo Exhaust, NG1’s aftermarket exhaust system, to Gray Line licensees. 30,000 Trucks are involved. As an Allied Partner, NG1 joins a select group of brands whose products and services are available to Gray Line licensees, providing these companies with access to the advanced fuel savings of NG1 TechFlo Exhaust.  Gray Line Worldwide’s Allied Partners include several established and respected transportation industry companies, such as Bridgestone, Detroit Diesel, Motor Coach Industries and Prevost. Gray Line licensees are currently installing NG1 TechFlo Exhaust systems at select locations across the U.S., with plans to roll out the product to all U.S. locations in the coming months and eventually to international sites. A recent composite credential report concluded the average fuel saving from using the TechFlo system was 12.33%, double the competitors.

2. US Department of Energy Grant Application Report NG1 TechFlo and UPS

An important second matter is the US Department of Energy Grant Application Report. In February 2016 as part of the continued research NG1 solicited a Department of Energy (DOE) funding opportunity announcement (FOA) DE-FOA-0001384 Innovative Dual Fuel Aftermarket Emissions Solution with United Parcel Service (UPS).   The exploratory research program is to develop an advance emission control system for Class 7 and Class 8 heavy duty vehicles equipped with an alternative fuels product variant.  The research will lead to the elimination or mitigation of the negative effects of current Diesel Particulate Filters (DPF) and Selective Catalytic Reduction (SCR) after-treatment systems by replacing them with a combination of symbiotic technologies specifically designed to enhance fuel savings and promote complete combustion reducing emissions. This DOE Report is expected in the next two months.

US Residential Fund CEO Interview

US Residential Fund is an ASX-listed business that is seeking to raise capital in order to transform over time from a property owner to a fund manager that retains exposure to property assets. Starting with a portfolio of 140 established rental houses in three US states, the fund has paid a A$0.06c pa distribution, which equates to a 10% return against the current capital raising offer price.

The fund is moving into the attractive multifamily property asset class and has established infrastructure in the US and Australia, which can be readily employed to execute the funds management strategy.

Please listen to Andrew Meakin, Managing Director of US Residential Fund below.

Ai-Media FY16 Update: Broadcast Deal Signed with Seven Network, Mobile App Launched & US Subsidiary Established

Ai-Media signed a multi-year broadcast captioning deal with the Seven Network, covering all offline and live captioning for its television channels including Seven, 7Two, 7Mate and 7Flix. The contract commences on 1 August, ahead of the Rio Olympics which begin on 5 August. Additionally, contract extensions with both Foxtel and the Nine Network were secured.  The Company has sustained its Captioning Quality record, with the most recent independent audits revealing scores of over 99.6%.

Development of the Visible Classroom product in conjunction with the University of Melbourne has continued, and a mobile app was launched in the App Store and Google Play store worldwide.  The App allows teachers to upload recordings from their classroom for analysis,  and download their transcript, analytics and insights that drive behavioural change.

In March 2016, Ai-Media Inc, a wholly-owned US subsidiary was established.

ABOUT AI-MEDIA

Ai-Media delivers live & offline television captioning under long term contracts for many Foxtel channels, education captioning for schools and universities, and high quality transcripts to 99.90% accuracy for government and corporate clients.

Ai-Media’s flagship technology solution, Ai-Live has proven effective in pilots supported by Commercialisation Australia for deaf students at school & university. Current clients include the NSW & Victorian education departments, & Macquarie University.

Bulletproof FY16 Update: Acquired Infoplex, Raised $3.8m, Over-Subscribed Share Purchase Plan

Bulletproof Group Limited (Bulletproof – ASX code BPF) enjoyed a very active FY16. The Company successfully acquired Infoplex in October 2015 for $3.55m, following a capital raising of $3.8m. A Share Purchase Plan in November was over-subscribed and raised a further $2m. The Company completed its acquisition of New Zealand AWS partner Cloud House in February 2016. 1H16 results included 90% revenue growth year on year, with strong underlying profitability growth compared with 1H15.

A new Melbourne office was opened in September 2015, and a new Sydney CBD office in June 2016, consolidating personnel from acquisitions and existing Rosebery offices.

Bulletproof was recognized as Frost and Sullivan's Managed Service provider of the year 2015, in November. Bulletproof presented with major client Crownbet at the AWS Summit in April 2016, demonstrating the key value Bulletproof delivers for customers.

Bulletproof also presented at the AWS summit Auckland in June 2016, co-presenting with customer Xero on cloud security best practices. These awards and events reflect Bulletproof's status as the leading end to end cloud services provider in Australia and NZ, and the only AWS Premier Consulting Partner across both countries.

Bulletproof's FY16 guidance indicates revenue growth of 67% year on year to $47m, with underlying EBITDA expected to be between $4.6m and $4.7m (up from $4.2m in FY15), and EBIT between $600k and $700k, slightly down on FY15's $850k, attributed to some customer-side delays in project work reducing profitability towards the end of the half. Customer wins throughout the year included Barbecues Galore, Nestle Australia, Minter Ellison and Fred Hollows Foundation.

ABOUT BULLETPROOF 

Bulletproof Group Ltd (ASX:BPF) is a publicly listed company with offices in Sydney, Melbourne and California. Founded in 2000, Bulletproof is the leading cloud services provider to business, enterprise and government customers.

Bulletproof has consistently been first to market with public and private cloud based services and innovations, including to launch a public cloud service in Australia and the first to launch a managed Amazon Web Services (AWS) offering. Bulletproof became an AWS Premier Consulting partner in 2013 and was re-certified in 2014. Bulletproof’s recent acquisition in the Cloud Consulting space has further enabled the company to help companies leverage the cloud as they disrupt their market, by simplifying the complexity of cloud and enabling its customers’ rapid transformation.

Peppermint Signs Agreement with Largest Bill payment Business in the Philippines

18th July 016, ASX Announcement

Highlights

  • Peppermint will be the first to provide a mobile application to CIS BAYAD CENTER, INC- the largest bill payment business in the Philippines.
  • Peppermint will work with the BAYAD CENTER (connected more than 200 billers) to provide its proprietary mobile application called the “Peppermint Payments Collection Solution”.

Peppermint Innovation Limited (ASX:PIL), an Australian mobile banking, payments and remittance technology platform focused on providing vital access to banking services for millions of people not currently linked to traditional banks, is pleased to announce that it has now signed a commercial agreement with CIS BAYAD CENTER, INC. (“CBCI”).

CBCI is a wholly owned subsidiary of MERLCO (Manilia Electric Co.), and the CIS Bayad Canter business model (the first of its kind in the Philippines) is now the leading brand in the country. Bayad Center provides the public with a worry-free payment collection in utilities, government service, telecommunications, cable TV, Internet, insurance & pre-need, healthcare, transportation, electronic wallet, credit card, real estate, financial services, art and entertainment and charity donations.

To view the full announcement, please click on the button below.

Video: iComplii Founder and CEO Jason Knight Featured on Ventured

iCompLii Founder and CEO Jason Knight talks about being the founder of iCompLii, some of the pains and also the gains. iCompLii is changing the way compliance is managed at both a personal and business level by removing the risks.


ABOUT ICOMPLII

iCompLii is revolutionising compliance for individuals and businesses with portable profiles for both human and physical assets, allowing flexibility and more certainty in workplaces that are becoming more contingent and a decreasing average length of employment.

The highly developed SaaS cloud-based platform handles the administration burden of complying with regulations and offers a service to candidates which enables them to efficiently store and manage all their personal and working information (including skills and certificates). iCompLii already has over 18,000 profile holders register since the platform was opened to the public in mid January 2016.

Last Chance for Legado Partners Melbourne Round Table Sessions

Private Capital Investments Round Table

Last Seats Available for next weeks Melbourne sessions.

Legado invites you to attend an early comment forum with current and prospective investors.

This session is to provide you with an opportunity to gain insight into specific deals in our pipeline and share with us your perspective on the opportunities in front of us.

There are some very good private businesses for sale in Australia where you can buy them at much lower price than listed shares or large corporates. There are also some very good management teams who run these businesses, who need cash and resources to help with the transition for the current owner.

If you would like to attend one of our sessions please follow the below links to get your free ticket through Eventbrite.com. Spaces are limited and registering is essential.

Is Legado right for you? 

If you have investable funds of $500,000 or more, you invest for the long term, you seek outstanding returns of 20%+, and you have an understanding or an appreciation of business then you may be a good fit. Please contact our office for further information or to understand the investment options that Legado offers.

Melbourne

Thursday 21 July 2016,
3:00PM & 5:00PM
Exchange Tower, 530 Little Collins Street, Melbourne.

Register Now

Sydney

Wednesday 17 August 2016,
3:00PM & 5:00PM
Level 9, 55 Hunter Street, Sydney.

Register Now

Canberra

Thursday 18 August 2016,
3:00PM & 5:00PM
Legado Office, Level 1,
113 Canberra Avenue, Griffith.

Register Now

Brisbane

Wednesday 21 September  2016,
3:00PM & 5:00PM
Brisbane CBD – venue to be confirmed.

Register Now

Martin Aircraft Company Signs Alliance Agreement with AvWatch

18th July 2016, ASX Announcement

Martin Aircraft Company is pleased to announce that it has signed a formal Alliance Agreement with AvWatch Incorporated, USA on 18 July 2016.

Avwatch is a US business that harnesses innovative and proven technologies to support, enhance and train Federal, state and local government agencies in support of homeland security and disaster recovery. The company was founded in 2008 and consists of nationally recognised Homeland Security experts who are well-versed in military, Federal, state and local disaster response planning and response protocols.

In terms of the agreement, Avwatch and Martin Aircraft Company will work together, along with input from already identified customers, to develop specific capabilities for the North American First Responder and Homeland Security sectors, key markets for the First Responder Martin Jetpack. The agreement also creates the platform to seek research and development funding for the further development of the Martin Jetpack to meet specific identified US first responder requirements.

To view the full announcement, please click on the button below.

WYZA Reaches Milestone of 200,000 Weekly Subscribers

WYZA.com.au, Australia’s fastest growing digital destination for people 50 plus today announced that it has just exceeded 200,000 subscribers to its weekly newsletter.

With the WYZA subscription base growing at a stunning rate – tripling in size over the last 12-15 months (59,000 in April ’15 to 151,000 in June ’16 and 200,000 in July ‘16), Managing Director Michael Farley said that reaching 200,000 subscribers was a significant milestone for WYZA – a 100% YOY growth – reflecting the massive engagement of our 50-plus demographic.

“200,000 weekly subscribers means that WYZA is better able to directly reach this exclusive and hard-to reach audience of people 50 , significantly out-performing our competitors in this category “ says Mr. Farley.

A recent research study* conducted by the site found that far from winding down, people over 50 are still forward and outward looking – wanting to travel, get or stay healthy, explore and buy new things or switch things up.

“60 is the new 40 with our users telling us they feel younger than their age and are optimistic about the future. Travel is the clear No 1 leisure passion for the WYZA audience with more than three quarters of them stating they intend to book a holiday within the next year. Getting or staying healthy, decorating or renovating their home and studying something new are all on the top of the list of things people over 50 are planning to do,” Mr. Farley added.

Less than 2 year old, WYZA.com.au has over 430,000 monthly visitors, generates more than 1.2 million page views, 24,272 Facebook followers and 200,000 weekly newsletter subscribers.

“The WYZA generation is a little older and a lot WYZA. They are savvy genre-defying consumers and are determined not to be ignored,” Mr. Farley said.

“What is also clear is that the old model of reaching people in this age group has changed. Some 88% told us that they dislike the way advertisers currently communicate with them. Remarkably, they spend an average of five hours a day on the internet, social media and their mobile phones.

“Against stereotype, 80% of WYZA respondents have a positive attitude towards technology, 90% have purchased online and 25% do so on a weekly basis.”

Video: LifeSherpa Investor Presentation June 2016

Please watch LifeSherpa’s Founder & CEO, Mr Vincent Scully, talk in further detail about the company and investment offer at the recent Sydney Investor Evening June 2016.


ABOUT LIFESHERPA

Lifesherpa is Australia’s first online financial advice service providing affordable, accessible financial advice for a new generation of Australians online combining technology with the human touch. Our proprietary online tools and efficient back office built on Salesforce, allows us to profitably service the needs of clients who do not have sufficient assets to be attractive to traditional financial planners.

For just $15/month, Lifesherpa members get their own advisor, access to the website resources and commission free advice on budgeting, debt elimination, super, insurance and home loans.

 

BioDiem Non-Renounceable Pro-rata Entitlement Offer Closes July 29th

15th July 2016

BioDiem’s pro rata nonrenounceable Entitlement Offer to raise up to $1,250,000 (before costs) is closing soon.

Funds will be used to progress the next phase of commercialization of BioDiem’s influenza vaccine (LAIV) licensing business; and its antimicrobial, BDM-I, in development for the treatment of infectious diseases through BioDiem’s subsidiary, Opal Biosciences Limited (“Opal Biosciences”).

A copy of the BioDiem Prospectus and a personalised entitlement and acceptance form, including BPay details has been mailed to shareholders. The Prospectus is available on our website.

ABOUT BIODIEM

With rising concern about viral infections, “superbugs” and antibiotic resistance, BioDiem is well-positioned with its focus on commercialisation of infectious disease therapies and vaccines. An established ‘flu vaccine licencing business is drawing revenue from commercial partners in India and China. Nasovac-S™ is marketed in India and has recently received WHO prequalification which allows export to new markets.

New anti-infectives are needed due to increasing resistance to existing antibiotics, more difficult-to-treat infections, and paucity new treatments. BioDiem’s subsidiary, Opal Biosciences Ltd is an innovative player in infectious disease treatment, targeting human infection – a high growth, commercially attractive market segment.

Video: 4Dx Investor Presentation June 2016

Please watch 4Dx’s Executive Chairman, Dr Andreas Fouras, talk in further detail about the company and investment offer at the recent Sydney Investor Evening June 2016.


ABOUT 4DX

4Dx brings a technological solution set to disrupt this multi-billion dollar sector through compelling unique competitive advantages over existing respiratory diagnostics. The respiratory diagnostic sector represents a global market of over $25B perannum. Currently served by out of date technology, 4Dx has enormous scope for financial success as well as life changing advancement for medicine.

Offering more detailed information, faster validation of treatment efficacy, lower costs, and reduced radiation dosage, 4Dx allows for earlier detection of disease and earlier intervention.The ability to identify lung issues earlier is creating a critical shift in the practice model from cure to prevention.

Video: Real Estate Investar Investor Presentation June 2016

Please watch Real Estate Investar’s Managing Director & CEO, Mr Clint Greaves, talk in further detail about the company and investment offer at the recent Sydney Investor Evening June 2016.


ABOUT REAL ESTATE INVESTAR

Real Estate Investar (ASX:REV) is a leading provider of integrated services to property investors to assist in the identification, analysis, acquisition, tracking and accounting of investment property. With over 190,000 investors accessing free online member services, and over 2,800 paying subscribers utilising its platform to build and manage their portfolios, Real Estate Investar helps investors generate wealth through property investment.

By providing an end‐to‐end online solution Real Estate Investar generates recurring subscription revenues as well as a number of transaction based revenues from services including mortgage broking and investment property sales.

 

Recording of Crowd Mobile Investor Webinar Available

15th July 2016, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) advises that a recording of the investor webinar which was held on Thursday 14 July  2016 is now available for viewing on the Company’s website via the following link:

To view the full announcement, please click on the button below.

ABOUT CROWD MOBILE 

Crowd Mobile is a global m-Content, m-Payments, m-Commerce, mobile entertainment and micro job company.

Crowd Mobile listed on the ASX in January 2015 through a back door listing into Q Limited (ASX: QXQ) and dual listed Frankfurt/XETRA June 2015.

To view the full announcement, please click on the button below.

Actinogen Medical US Roadshow Investor Presentation July 2016

15th July 2016, ASX Announcement

Focusing on an innovative approach, through the inhibition of cortisol production, for treating cognitive impairment in chronic neurodegenerative and metabolic diseases

Xanamem™:  A prime investment opportunity 

  • Alzheimer’s – a significant unmet need in a huge and growing global market
  • Xanamem™’s innovative, differentiated mechanism of action targeting the stress hormone cortisol
  • Evidence Xanamem™ is both symptomatic and disease modifying
  • Phase II study funded through to completion
  • Patent protected to 2031 – composition of matter
  • Value enhancing additional indications in substantive markets of interest to big pharmaceutical companies – Alzheimers disease, Diabetes, Parkinson’s disease

To view the full announcement, please click on the button below.

Analytica’s AutoStart Burette Granted US Patent

15th July 2016, ASX Announcement

Analytica (ASX:ALT) is pleased to announce that the AutoStart® burette system has been granted patent protection by the US Patent and Trademarks Office.

US Patent 9352080 has a priority date of 13 October 2005 and will expire on 17 Jan 2031, provided all renewal fees are paid.

CEO Geoff Daly said “Obtaining patent protection in the world’s largest medical device market is a major milestone and an important step in the commercialisation of the AutoStart infusion System. The patent process is lengthy and complex, with this national phase patent taking more than  10 years from the priority date. This patent is one of a number of AutoStart burette patents being pursued in the major medical device markets.”

To view the full announcement, please click on the button below.

iFAST Notification Of Results Release

14th July 2016, iFast Corporation

The Board of Directors of iFAST Corporation Ltd. (“the Company”) wishes to inform that the Company will release its unaudited financial results for the second quarter ended 30 June 2016 before market trading hours on 29 July 2016.

ABOUT IFAST CORPORATION 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Incorporated in the year 2000 in Singapore and listed on the SGX-ST Mainboard on 11 December 2014, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

To view the full announcement, please click on the button below.

Bulletproof FY16 Results: Revenue up 67%, Closing Balance of $4.6m

14th July 2016, ASX Announcement 

FY16 Results Guidance

  • Full year revenues expected to be in line with market expectations $47m, up 67% on FY15
  • Underlying EBITDA expected to be $4.6m – $4.7, up from $4.2 in FY15
  • Underlying EBIT expected to be $600k – $700k, down from $850k in FY15
  • Positive operating cashflow, with closing cash balance of $4.6m

Bulletproof wishes to advise the market of its expected FY16 full year results and trading conditions with this interim update.

FY16 Results 

The ongoing investment in accelerated growth from organic and acquired revenue sources is expected to deliver a revenue figure in line with market expectations, at $47m, a 67% increase on FY15, and well above market revenue growth rates of 25-30%. Of this revenue, recurring sources are expected to make up close to 80% of the total figure. Cash flow is positive for the year, with a closing cash balance of $4.6m.

To view the full announcement, please click on the button below.

Folkestone Maxim A-REIT Securities Fund June 2016 Report: +4.02% Returned

For the month of June 2016, the Fund returned +4.02% (on an After Fee but Before Tax basis), outperforming the Fund’s Benchmark (S&P/ASX 300 A-REIT Accumulation Index) by 0.49%.

The June 2016 Monthly Report provides a snapshot of the Fund and the A-REIT sector’s performance.

Read more.

Fund Benefits

The Folkestone Maxim A-REIT Securities Fund is a high conviction, actively managed fund, that gives investors exposure to a mix of quality listed A-REITs that own assets across the retail, residential, commercial, industrial and real estate related social infrastructure sectors.

  • Investment Expertise
  • Exposure to Listed Real Estate
  • High Conviction, Active Strategy
  • Daily Liquidity
  • Quarterly Distributions
  • Strategic Capacity Limit

Download PDS.

Folkestone Exchanges Contracts for the Acquisition of Watermark Castle Cove

Folkestone’s (ASX:FLK) real estate funds management subsidiary, Folkestone Real Estate Management Limited (FREML), announced on 7 July 2016 that it had exchanged contracts for the acquisition of Watermark Castle Cove, an award winning retirement living community on Sydney’s lower north shore, the first asset for its seniors living platform and the Folkestone Seniors Living Fund No.1 (FSLF).

Mr Greg Paramor, Managing Director of Folkestone said “We already have more than $780 million in funds under management in social infrastructure through the ASX listed Folkestone Education Trust, Australia’s largest owner of early learning properties, and the unlisted CIB Fund which owns police stations and courthouses in Victoria. Our move into seniors living is a natural progression of our strategy to be a key player in the social infrastructure space.”

As Folkestone’s first seniors living fund, FSLF’s investment strategy is to own and develop high quality retirement living communities in Sydney via investing in operating facilities and/or partnering with quality operators to own and/or develop retirement living communities.

Strong Interest for Altech at the International Sapphire Industry Exhibition

14th July 2016, ASX Announcement

Highlights:

  • Strong interest for Altech’s entry into the high purity alumina market
  • Altech’s proposed nano particle size HPA product range well received
  • Vertically integrated  production model will ensure security of quality of HPA supply
  • Forecast tightening of supply side of the HPA market as demanded rapidly expands
  • HPA analytical and production data available to end-users on-line

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide a summary of its recent attendance at the 2nd International Sapphire Industry and Touch Screen Technology Exhibition in Shenzen, China (June 23-25 2016).

Altech’s presentation at the exhibition generated strong interest from synthetic sapphire producers, who welcome the prospect of the Company’s entry into the high purity alumina (HPA) market via its proposed 4,000tpa Malaysian HPA plant.

To view the full announcement, please click on the button below.

Mobotech Update June 2016: US Showcases & Demonstrations Continue; Last Investment Round Still Available

Another busy month showcasing and demonstrating the Mobots around the US.

Greg Ecker (President, Magline) and Steve Haythorne presented the Mobot to the 3PL & Chief Supply Chain Managers Summit in Chicago. This event was attended by 400+ senior logistic, retailer and manufacturing managers as a means to keep pace with innovation and meet with industry enablers to solve industry pains. The highlight for Mobotech were introductions to Wal-Mart’s and Kroger who were interested in the Mobotech solution for automating their last mile delivery system.

Mobotech also conducted demos to two key US companies based in Texas. Dean Foods, the biggest milk distributor in the US and Frito-Lay, a massive chips & dips, Pepsi owned Company. Both have last mile distribution issues that the Mobots potentially solve. They have since provided specs for Mobots and both are looking to schedule trials next month. As well as Dean Foods & Frito-Lay we also have trials being scheduled with Dollar General, PepsiCo and Saddle Creek Logistics coming up.

In order to support these trials, Magline have funded the shipping of the remaining four Mobots from NZ to the USA. They also now have the manufacturing and BOM plans to support the Mobots through these trials.

The last round still has NZ$200K available for investing should anybody wish to help with the final pre-sales push and take advantage of a de-risked opportunity.

ABOUT MOBOTECH

Mobotech design and build mobile robots (Mobots) for the fast moving consumer goods (FMCG) industry. The Mobot is a patented, smart, connected load transfer vehicle for use in logistic/supply chains to help save these companies millions in transportation costs, increase inventory control and injury prevention.

Universal Biosensors 1H 2016 Financial Results Webcast

13th July 2016, ASX Announcement

Universal Biosensors (ASX:UBI) will be hosting an investor webcast to discuss the 2016 Half Year Financial Results on Thursday, 21 July 12.00pm noon AEST. The call will be hosted by Universal Biosensors Executive Chairman Andrew Denver.

Shareholders are invited to register for the live webcast of the Half Year results via the button below:

To view the full announcement, please click on the button below.

PANALITIX Unique Accounting Application Now Available at Intuit Marketplace

12th July 2016, Yahoo Finance

PANALITIX, the global leader of a subscription-based community for accountants and financial advisors, recently announced its availability at the Intuit Marketplace, a longstanding aggregate market of best in industry software to enhance a variety of business functions. PANALITIX software syncs with QuickBooks Online, Xero, and MYOB accounting solutions. In conjunction with its availability through the marketplace, PANALITIX also received a nomination for the User Favorite Awards in the Business Intelligence category, presented by Accountex and AccountingWEB. Designed to honor elite accounting technology solutions, the Accountex award comes directly from user votes, with only one award in each category.

“The PANALITIX business intelligence application gives accountants all the tools necessary to provide higher value services to their clients,” said Co-Founder and CEO Rob Nixon. “This is necessary in today’s market, where accountants have transcended beyond the traditional bookkeeping and reactive calculation roles and have become proactive business advisors. PANALITIX is dedicated to empowering accountants, and business intelligence functions are a key way to do this. We couldn’t be more honored that our users agree.”

To view the full announcement, please click on the button below.

DomaCom FY16 Update: $12m Raising in Pre-IPO Funding, $250m Crowd-Funding Campaign Launched, IPO Prospectus

DomaCom Limited, owner of Australia’s first regulated fractional property investment fund, has been well received by Australian investors, raising $12m in pre-IPO funding over the past 18 months. DomaCom has demonstrated the versatility of its revolutionary investment model when it launched a $250m crowd-funding campaign to buy the iconic pastoral empire S Kidman & Co, Australia’s largest landholding. The pitch targets investors wanting to keep Kidman Station Australian-owned. Registrations of interest exceed nearly 5,000 investors who have pledged about $70m.

Following a 5-year development and launch phase which saw DomaCom acquire 16 properties for investors and initiate another 37 bookbuilds, the company is now taking the next major step on its corporate journey with a listing on the Australian Securities Exchange (ASX).

DomaCom is seeking to raise $10m, with the minimum of $5m already underwritten by existing shareholders and new investors. The IPO Offer opened on July 11, 2016 and is scheduled to close August 5, 2016.

ABOUT DOMACOM 

DomaCom Ltd is the first and only regulated fractional property platform in the country. Following a 5-year development and launch phase which has seen the company acquire 16 properties and initiate another 37 bookbuilds, DomaCom is taking the next major step in its corporate journey with a listing on the ASX. DomaCom is seeking to raise $10 million in the IPO, with $5 million already underwritten.

To receive a copy of the DomaCom IPO Prospectus or Receive Offer, please click the button below. 

QBiotics FY16 Update: $16m Raised, New Appointments to Board, Preparation for Further Registrations

The last 12 months has seen QBiotics strengthen both its board and balance sheet. Over the last 12 months, the company has raised $16m and will soon raise a further $10m, giving them a balance sheet of approx $30m. These funds will be used to further develop their two drug products EBC-46 (cancer) and WH-1 (wound healing).

The Board has also been strengthened with the following appointments:

  • Rick Holiday Smith has been appointed as Chairman of QBiotics. Rick is currently the Chairman of the ASX (ASX:ASX) and Cochlear (ASX:COH)
  • Dr Bruce Robinson has joined as a Non-Exec Director. Dr Robinson was Dean in the Faculty of Medicine at the University of Sydney and was Head of the Division of Medicine at the Royal North Shore Hospital
  • Andrew Denver has also joined as a Non-Exec Director. He is a Director of Cochlear, Vaxxas Inc and SpeeDx Pty Ltd

QBiotics is also preparing for registration of EBC-46 for dogs by implementing the first part of its marketing strategy. In May this year CEO Dr Victoria Gordon did a presentation to specialist oncologists and general veterinary practitioners at the World Veterinary Cancer Congress in Brazil. They have also completed a major milestone in the Chemistry Manufacturing and Controls (CMC) program with the submission of the EBC-46 Common Technical Document (CTD) Phase 1 to the US FDA’s Centre for Veterinary Medicine (CVM). They has also recently commenced a Target Animal Safety Study (TASS) for the veterinary program after having obtained regulatory concurrence from the FDA-CVM.

ABOUT QBIOTICS LTD

QBiotics Limited is developing a pipeline of promising drugs in the area of cancer and wound healing. Its lead drug, EBC-46, targets solid tumours and is currently in late pre-clinical development in preparation for a Human Clinical Phase I/II trial with the USA’s FDA. EBC-46 is also in late stage development for the veterinary market through the USA’s FDA-CVM.

Analytica Receive FDA Approval for Over the Counter Clearance PeriCoach

12th July 2016, ASX Announcement

Analytica Ltd (ASX: ALT) is pleased to announce that the US Food and Drug Administration (FDA) has granted the company over-the-counter (OTC) clearance for the PeriCoach system, previously available in the US by prescription only.

The PeriCoach is a unique medical device that assists women to exercise their pelvic floor muscles in order to reduce or eliminate Stress Urinary Incontinence, a condition that affects 1 in 3 women.

“Women can use pelvic floor exercises or “Kegels” to reduce or eliminate urinary incontinence symptoms, and with PeriCoach now available over the counter, home training just got a lot more convenient,” said Leslie Rickey, MPH, MD, Associate Professor of Urology and of Obstetrics, Gynaecology and Reproductive Sciences and Fellowship Director of Female Pelvic Medicine and Reconstructive Surgery, Yale School of Medicine.

To view the full announcement, please click on the button below.

Cellmid FY16 Update: Strong Revenue Growth, Full Range Launched, Presence Built in Major Markets

Cellmid, a life sciences accelerator, continued to build its consumer health business during FY2016 and is on track to deliver strong revenue growth for the period.

The Company launched its full range of clinically validated hair growth products, evolis®, in Australian pharmacies in May 2015, and doubled its Japanese distribution.

Most recently, Cellmid launched an evolis® Professional range for the hair salon market, opening up major opportunities in anti-aging hair care.

With its category leading product, Cellmid started to build presence in major markets (USA, China) in 2016, planning commercial launches in the next 12 to 18 months in these regions.

ABOUT CELLMID LTD

Cellmid (ASX: CDY) develops innovative therapies and diagnostics for cancer, inflammation and heart attack. CDY has the largest global IP portfolio related to growth factor midkine (MK). Its most advanced program is for MK antibodies targeting cancer/inflammation. CDY is also developing MK protein to treat heart attack and other ischemia. CDY’s first product is a blood test measuring serum MK. MK is a powerful biomarker of early cancer. CDY’s subsidiary Advangen develops and sells scientifically validated products to prevent and treat hair loss with products that have a well understood, safe and novel mechanism (inhibiting FGF-5). Two product ranges are on market, for pharmacies (évolis®) and professional hair salons (Jo-Ju® & Lexilis®).

Avenir Capital FY16 Update: Portfolio Grew by 30%, Delivered Gross Returns of 17%, Attractive Long-Term Returns for Investors

Avenir Capital, has now been operating for 5 years and delivered gross returns of 17% per annum. The companies in our current portfolio grew operating income, on average, by 30% in 2015 (median growth of 25%) and have continued that growth in 2016. The portfolio trades at what we believe to be attractive prices of roughly 7 times operating income and has the potential for ~60% upside based on our intrinsic valuation.

Avenir continues to seek to generate attractive long-term returns for our investors via investing in fundamental, value oriented and special situation investments in global equity markets.

ABOUT AVENIR CAPITAL

Avenir is a specialist global equities funds manager. Our core philosophy is to invest in quality businesses with growth propects for the long term. Through fundamental, value-based research and analysis our aim is to acquire long-term assets that due to special circumstances and/or internal/external “change” can be acquired at a significant discount to their current or future intrinsic value.

Starting and Building Wholesale Investor: 8 Years On

11th July 2016, LinkedIn

Letter form Steve Torso, Founder and Managing Director, Wholesale Investor

I Founded Wholesale Investor (“WI”) in Oct 2008 to provide a way for high net worth investors to get access to early stage companies. It is a week I will never forget because as we were launching, the Dow Jones was dropping 20%. At that time, it was obvious that the market was quite fragmented with no central place for investors to discover deals and news related to those companies.

Since our launch, WI has built a large following in Australasia amongst HNW and sophisticated investors with over 14,000 subscribers in Australia and Asia. The business has been built on the simple premise of using an online and event based platform to connecting emerging companies and investors.

Recently it was announced in the AFR that Investec Australia Limited (“Investec”) has made an investment in Wholesale Investor. This investment provides us with the capital to accelerate our growth in the next phase of our journey, along with providing companies and investors more services.

It is amazing how quickly the 8 years has passed. It is also fascinating to know that our simple idea which started out as a glossy magazine, has now enabled us to host 22 Showcase events, in 6 countries, to over 3500 attendees and profile over 120 companies in the last 12 months alone.

Whilst building the business has come with its fair share of ups and downs, the passion at our core has always been about creating more visibility and opportunity for innovation and emerging companies. Thank you to our Advisor Jamie Olsen and CMB Capital, who have been great in helping us strategically and securing investment.

In the first 6 months of this year, over $22mill has been raised as a result of our services. In our recent March and May series of Investor events in Sydney and Melbourne, we have already seen over $4mill invested (from each series) into our clients as a direct result. From our Singapore event 1 month ago… over $2mill has already been secured. This is an exciting time for Emerging Companies to say the least!

We are pleased to welcome Investec as a shareholder. From our first discussions, we realised their shared enthusiasm for the Emerging Company space. Globally, Investec has over 8000 staff, $90billion in AUM and a strong presence in South Africa, UK and Hong Kong. With a history of backing entrepreneurs, Investec recently launched their Emerging Companies Division and will be actively Investing in growth companies throughout the region.

As a subscriber to Wholesale Investor, it is important for you to know we are currently working on the long overdue redevelopment of our platform. We look to make your experience in discovering and investing in opportunities, simpler, faster and more targeted to what you seek. We thank you for your support, event attendance and investment into our clients.

To our Corporate and Event Partners, we wish to say thank you. Without you… the capital being raised and opportunities (locally and internationally) in front of our clients is not possible. PwC, DLA Piper, NZTE, Shareinvestor, Austrade, ASX, AusBiotech, SGX and Bloomberg to name a few.

To our clients, thank you for trusting us with the promotion of our Capital Raising and Investor Profiling. The Wholesale Investor team works hard to facilitate this process and we look forward creating new opportunities in the future for you.

Our ambitions for what is possible… have grown. It is our mission to become the leading Asia-Pacific destination for Trade and Investment with Emerging Companies. Join us for the next phase of journey.

Jetpack Aviation FY16 Update: JB-9 Jetpack Unveiled, Global Media Coverage, US Military R&D Projects

In November 2015, Jetpack Aviation unveiled its JB-9 Jetpack to the world’s via a demonstration flight around the Statue of Liberty in New York. The JB-9 is a jet engine powered Jetpack weighing just 45kgs. After the flight the company received significant global coverage media including a feature in the Wall St Journal, the Gadget Show (UK) as well as countless news stories. They also quickly caught the attention of the US Military, who requested a demonstration flight in December 2015. JPA is now working closely with the US Military on R&D projects to learn how to best deploy the Jetpack technology.

The company also upgraded the JB-model and the 2nd and 3rd packs are currently in production. They are also working on a parachute and airbag system to make the Jetpack safer and more widely useable.

Jetpack Aviation is also in detailed discussions with a globally recognised, high profile FMCG brand about developing a branded Jetpack demonstration team. The plan is for this Jetpack team to conduct demonstration flights at major sporting events and attractions around the world.

In 2016, Jetpack Aviation, through their Corporate Advisors Axstra Capital, have raised close to $1m and are about to launch a capital raising through Seedrs in London that will value the company at over $60m.

ABOUT JETPACK AVIATION 

Jetpack Aviation, a company with operations based in Los Angeles CA, has created the world’s first true Jetpack – the JB-9. This compact Jetpack is powered by twin TurboJet engines and is a true breakthrough in global aviation.

It is capable of vertical takeoff and landing (VTOL), is extremely small and can easily be carried around by the pilot. It is very powerful, capable of rapidly lifting a 100kg (220lb) pilot thousands of feet into the air, at speeds of over 110km/h (68mph). It is fuelled by kerosene and can remain airborne for up to 5 mins, allowing the pilot to travel a distance of approx. 15kms.

1Above FY16 Update: North America Launch, Revenue Increased 33%, New Management Team

1Above is the worlds only complete solution to jet lag and travel recovery servicing a potential market of over 3.6b air travel passengers. 1Above is now positioned for global expansion. After road testing their model for the past 4 years across NZ & Australia the choice has been made to focus on partnering with global travel retail partners to expedite scale in key travel hubs. 4 major customers can provide access to 90% of the worlds biggest airport hubs and markets.

In the past 12 months we have launched into North America and will be present in over 550 stores by the end of 2016. A global deal has been struck with WH Smith International across 11 countries, the UK, Denmark and Sweden and discussions have started with Lagardere, the worlds biggest travel retailer to potentially secure 1,200 store locations through their network.

Revenues have increased 33% to $2.4m (FY16) with FY17 revenues forecasted to be $NZ3.2m, FY18 $NZ8.7m and FY19 $NZ12.8m. Gross margin is maintained at over 60%.

New management team has been established with over 70 years of combined FMCG experience across the globe. Looking to raise $NZ2.5m in July 16 with $NZ1m already confirmed.

ABOUT 1ABOVE 

1Above – The Flight Drink- is a functional beverage that helps address the pain points of air travel: travel fatigue / jet lag, hydration, circulation, and immunity. It does this through its clinically supported ingredients and the product is available in Ready to Drink (RTD), concentrate and effervescent tablet formats.

1Above’s core purpose and brand proposition is to help airline passengers “arrive ready” every time.

BIG Un Ltd See Strong June Quarter Revenues; Up 20% on Guidance and 53% on Prior Quarter

12th July 2016, ASX Announcement

Highlights:

  • Revenue growth accelerated towards end of the June quarter with cash receipts exceeding $1.8m
  • Result 20% ahead of market guidance provided on 15 June 2016
  • Growth was very strong at 53% on the prior and 676% on the previous corresponding period last year
  • Key drivers behind this result were a combination of strong customer acquisition and an increase in revenue per customer, which is now above $1,200 across enterprise and SME customers
  • Outlook for the September 2016 quarter is very encouraging with a strong pipeline and significant carry over increase in recurring revenues
  • Continued rapid market penetration combined with major product enhancements underway positions the company to emerge as the dominant video marketing platform for SMEs

Big Un Limited (ASX: BIG, ‘BRTV’ or ‘the Company’) is pleased to provide a review of its activities for the three-month period, ended 30 June 2016.

To view the full announcement, please click on the button below.

Chris Ridd Former MD of Xero Invests in Seera

12th July 2016, The Australian By Supratim Adhikari

Cloud-based unified talent management solution provider Seera has managed to entice former Xero Australia head honcho Chris Ridd as an investor as it eyes a listing on the Australian Securities Exchange next year.

The start-up, launched by former Seek CIO Brad Birchall, isn’t just interested in the undisclosed sum put into it by Mr Ridd, but is also looking to him for advice in an official capacity.

Mr Birchall said recruiting top shelf technology talent like Mr Ridd, with over 30 years of industry experience, including senior leadership roles with Xero and Microsoft, was a real coup for Seera.

“Chris is recognised as a true technology industry heavyweight who intimately understands what it takes for a cloud solution to go from start-up to ASX listing.

“We are thrilled Chris has joined the Seera team, both as an investor and as an adviser. Chris’s experience as MD of Xero is perfectly aligned with our growth strategy, and will be instrumental in our current capital raising and IPO plans.”

To view the full article, please click on the button below.

Métier Medical FY16 Update: Bronze Awarded in Major International Awards, $1.3 Million Raised, New CEO

Métier Medical Limited wins Bronze in a major international design awards competition and Raises $1.3 Million in the 6 months between January & June 2016.

Métier Medical has seen its safety hypodermic needle with unique secure-lok mechanism winBronze in the international A’Design Awards competition announced at a presentation held on Lake Como, Italy in June. The Award was won in the category of Scientific Instruments, Medical Devices & Research Equipment design.

The Company has raised $1.3 million dollars in the period January – June and will shortly be seeking to raise a further $2 million dollars in a second capital raise.

Tony Christmas has been welcomed into the Company as its new CEO and brings with him an extensive knowledge of the medical devices industry from an international and local background.

Earlier this year Métier Medical entered into an agreement with a Kenyan syringe manufacturer, supported by the Bill Gates foundation, to provide its safety hypodermic needles for use with ‘Reuse Prevention’ syringes used in immunisation programmes throughout Africa.

ABOUT MÉTIER MEDICAL 

Needlestick injury and reuse is an endemic problem throughout the developed and developing world and never has there been such an awareness of the financial and human cost as in recent times. The National Institute for Occupational Safety & Health estimates between 600,000 to 800,000 needlestick injuries every year in the USA alone and the figures in Australia are rising every year.

Unity Pacific Update: Sale of 308 Queen Street & Corporate Vehicle Process

11th July 2016, ASX Announcement

General Update

Unity Pacific Limited (ASX: UPG) (Unity Pacific) provides below a general business update following the sale of the 308 Queen Street/88 Creek Street, Brisbane property on 30 June 2016 and the announcement of the 80 cents per security capital distribution to be paid on 25 July 2016.

Corporate Vehicle Process

The Expressions of Interest process for the corporate vehicle concluded on 5 April 2016. The various expressions received were evaluated and certain preferred parties were selected. Discussions with those parties are still going.

To view the full announcement, please click on the button below.

iFAST FY16 Update: More Investment Products and Services, Stockbroking Firm in Hong Kong Acquired & New Partnerships

iFAST Corp has strived to enhance our platform’s capabilities by including more investment products and services, including bonds, ETFs and online discretionary portfolio management services. In 2016, our acquisition of a stockbroking firm in Hong Kong was completed in January, and we launched our stockbroking services on our HK B2B platform subsequently in June. Our China business was also soft-launched in March. We partnered an online media company to provide online fund transactional capabilities for their customers, and we also recruited wealth advisers under our ‘platform-cum-IFA incubator’ strategy to promote the wealth advisory industry in China. The Group also acquired a stake in the holding company of the iFAST India business in April.

ABOUT IFAST 

iFAST Corporation Ltd. (“iFAST Corp”) is an Internet-based investment products distribution platform. Incorporated in the year 2000 in Singapore and listed on the SGX-ST Mainboard on 11 December 2014, iFAST Corp provides a comprehensive range of services, including investment administration and transactions services, research and trainings, IT services and backroom functions to banks, financial advisory firms, financial institutions, multinational companies, as well as investors in Asia. The company is also present in Hong Kong, Malaysia and China.

VIDEO: Bioactive Laboratories Latest Investor Presentation at WI Investor Evening June 2016

Please watch Bioactive Laboratories Founder and MD, Rick Ferdinands, present at the WI Investor Evening June 2016.

ABOUT BIOACTIVE LABORATORIES 

Bioactive Laboratories specialises in plant based enhanced extracts. They have developed an anti-microbial that is potent to one of the worlds most deadly & widespread pathogens affecting over 200million people globally in 2012. The magnitude of this discovery has not been seen since the early 1970’s in a plant based treatment for a major infectious disease. As a consequence, Bioactive have forged a collaboration agreement and formed a new pharmaceutical company with the Walter and Eliza Hall institute of Medical Research (WEHI). Financial returns are estimated within 24 months.

 

ThinCats, Australia’s First Peer to Business Lending Platform Funds Largest Loan to Date – $500k @13% p.a. to a Public Company

We have just completed the funding of our largest loan to date within the stipulated listing period of 2 weeks. The loan for $500k @ 13% p.a. to be repaid with principal and interest over 60 months, was arranged for a public unlisted company, secured by real estate and personal guarantees of the majority shareholder/directors. 28 lenders (a small fraction of our over 350 lenders and their Self-Managed Super Funds) participated in this loan opportunity, investing an average of $18k each.

A truly fantastic result for our unique Peer to Business lending platform, as we embark on a growth phase with a number of loans between $50k to $300k to be listed over the next few weeks.

This is a good opportunity for you to consider becoming a lending member on the ThinCats platform and participate with fractional lending (to diversify risk) on secured loans, specifically for medium and longer term growth finance to a diverse range of Australian SME’s at attractive yields (13.9% weighted average yield on 25 loans totalling $3.25m since we commenced operations in early 2015) and no  defaults thus far.

To find out more go to www.thincats.com.au, read the information available via the “lending” tab and if you are a wholesale investor please register to become a member. Remember, registration is free and we do not take a spread on loans i.e. you earn exactly the full interest rate paid by the borrower whilst we earn a fee (charged to the borrower) for arranging the loan. And most importantly, unlike other platforms, we put up all the financials, a detailed Information Memorandum, Asset and Liability statements and Credit Bureau checks on all loans listed and you get to decide – to whom and how much you wish to lend (minimum $1k).

Watch DomaCom’s CEO Discuss Future IPO & Other Highlights


ABOUT DOMACOM

DomaCom is the first registered fractional investment platform in Australia, providing an online trading platform to enable buyers and sellers to transact for fractional ownership in high value assets such as property. Following a 5-year development and launch phase which saw the company acquire 16 properties for investors and initiate another 37 bookbuilds, the company is taking the next major step on its corporate journey with a listing on the Australian Securities Exchange (ASX). The Initial Public Offering (IPO) is set to raise $10 million with a minimum of $5 million already underwritten by new and existing shareholders.

 

Actinogen Medical Receive Positive Results from Phase I Study & Begin Phase II Study

Actinogen Medical is focused on the treatment of Alzheimer’s disease. The lead drug candidate Xanamem™, blocks the production of excess cortisol (the stress hormone), which is associated with cognitive impairment and the development of amyloid plaques and neurodegeration in the brain – the hallmarks of Alzheimer’s disease.

In 2015, ACW successfully demonstrated positive results from a Phase I study including that Xanamem™ efficiently crosses the blood-brain-barrier in concentrations adequate to inhibit the production of excess cortisol in the brain. Actinogen is now conducting a Phase II study in mild Alzheimer’s disease patients. Alzheimer’s disease is a multibillion-dollar market in desperate need of new treatment options.

The results from the Phase II study, if positive, will likely generate substantial investment or acquisition interest from major pharmaceutical players.

ABOUT ACTINOGEN MEDICAL 

Actinogen Medical Ltd (ASX: ACW) is an Australian, publicly-listed early clinical-stage biotechnology company focused on the treatment of cognitive impairment and Alzheimer’s disease.

Actinogen is developing Xanamem™ as a novel treatment approach to Alzheimer’s disease and other age-related neurodegenerative diseases. Xanamem™ displays high potency and selectivity for inhibiting the activity of a key enzyme in the brain, which converts cortisone to cortisol. Cortisol is also known as the stress hormone, and elevated levels of cortisol has previously been linked to cognitive impairment.  The pivotal human proof of concept study, also known as XanADu, commenced in 2Q2016.

4Dx FY16 Update: Share Price Increase to $312.50, Series A Wholesale Capital Raise, Signed Commercial Collaboration Agreements with Three Major US Hospitals

4Dx Ltd is an early stage medical technology company based in Melbourne, Australia, established to commercialise four-dimensional lung imaging technology: 4DxV. The Company had a hugely successful FY15/16 with Share price increasing to $312.50 (from $270 and $100 over the two past years). Major highlights include:

  • Establishment of Clinical Advisory Board (CAB) and appointment of two new board members;
  • Signed commercial collaboration agreements with three major US hospitals;
  • Opened a Series A wholesale capital raise of AU$4M together with a retail fundraising round;
  • Established a U.S. office with partial relocation of the management team to Santa Monica, Los Angeles; and
  • Increased infrastructure and personnel dedicated to R&D effort in new St Kilda Road office.

ABOUT 4DX

4Dx brings a technological solution set to disrupt this multi-billion dollar sector through compelling unique competitive advantages over existing respiratory diagnostics. The respiratory diagnostic sector represents a global market of over $25B perannum. Currently served by out of date technology, 4Dx has enormous scope for financial success as well as life changing advancement for medicine.

Offering more detailed information, faster validation of treatment efficacy, lower costs, and reduced radiation dosage, 4Dx allows for earlier detection of disease and earlier intervention.The ability to identify lung issues earlier is creating a critical shift in the practice model from cure to prevention.

Newground Capital Partners; Responding to Investor Demand for Real Estate Backed High Yielding Investments

2015 was successful for Newground, with major highlights including:

  • Granting of Australian Financial Services License from ASIC
  • The appointment of an experienced and well credentialed board of directors and management team
  • Establishing a presence in Brisbane, Sydney & Singapore
  • Closed 2 new funds and currently underway with another totaling more than $100m in project value

FY2017 will see Newground Capital Partners building momentum with a pipeline of over $30M under DD to be progressively released throughout the year off the back of an increasing demand from both domestic and international investors seeking real estate backed yield investments.

ABOUT NEWGROUND CAPITAL PARTNERS 

Newground Capital Partners is a boutique Real Estate Investment Manager connecting private capital to Australian residential development. Newground originates, structures, and manages both debt and equity investments into projects that have a clear exit strategy and provide an attractive return for the risks taken.

Their co-investment model means the company invests their own capital alongside, and on behalf of their clients’ who include High Net Worth Individuals, Self Managed Super Funds, and Family Office’s located in Australia and overseas. Newground’s point of difference is their award winning project advisory and distribution capability that works alongside their development partners to produce projects that sell out prior to completion and ensure the return of capital.

Altech Updated its Kaolin Mineral Resource at Meckering

8th July 2016, ASX Announcement

Highlights 

  • Kaolin Indicated Miner Resources of 11Mt @ 82.7% ISO brightness (JORC 2012)
  • Sufficient resources to provide <250 years feed-stock for the Company’s proposed Malaysian high purity alumina plant
  • Submission of mining proposal and mine closure plan imminent

Following the completion of grade control drilling in April 2016, Altech Chemicals Limited (Altech/the Company) (ASX:ATC) is pleased to announce an update to kaolin mineral resources for its 100%~owned mining lease (ML) M70/1334, at Meckering Western Australia.

The updated Mineral Resource is 11 million tonnes (Mt) of kaolin clay containing 45%minus 45 micron clay with a brightness of 82.7% (ISO standard), and is classified as Indicated.

To view the full announcement, please click on the button below.

Crowd Mobile Investor Webinar July 2016

8th July 2016, ASX Announcement

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3) (Crowd Mobile or the Company) advises that it will hold an investor webinar to discuss the proposed re-finance of debt facility which the Company announced to the market to the market on 30 June 2016.

The webinar will be held on Thursday 14 July 2016 at 4.30pm (AEST) / 8.30am (CEST).

To join the webinar, please register online at:

attendee.gotowebinar.com/register/1886737040261293315

To view the full announcement, please click on the button below.

Trinity Accommodation Regional Hospitality Fund FY16 Update: $12.5M Raid & Investors Paid More Than 10.5%

Trinity Accommodation Regional Hospitality Fund (TARHF) are pleased to announce that we have raised $12.5m and paid investors more than 10.5% p.a.   Further acquisitions are expected to increase this return materially.

TARHF is an unlisted property trust investing in high yielding real estate backed assets with excellent capital growth and downside protection over the medium term. TARHF purchases regional Australian hospitality properties with value added opportunities via capex and professionalising management.  This sector is generally uncorrelated to other asset classes making it ideal for all of yield, capital growth and diversification.

ABOUT TARHF

Trinity Accommodation Regional Hospitality Fund (TARHF) invests in Australian regional hospitality assets outside of the main capital cities. The fund aims to provide stable income returns of around 10% per annum plus capital growth of approximately 5% per annum (IRR basis) by selective asset acquisition and highly active management, including renovation and repositioning.

 

QLBS FY16 Update: Unsurpassed 6 Months, Virtual Business Advisor & Investment Interest to Follow

QLBS (Quantum Leap Beyond Spreadsheets) has had an unsurpassed first 6 months as the world realises the importance of cloud platforms for the measurement of compliance quality and business excellence. QLBS is positioned in the  $15 Billion Governance, compliance, risk market  reported to be growing by 14% per annum will reach $ 34 Billion by  2020.  Qimono  leads  as the  only universal cloud  platform for assessment, reporting and benchmarking in this segment.

Since January QLBS  launched the Australian Tourism Accreditation Program, the Australian Institute of Management Health Check assessment, The NZ Wine Export Quality assessment, The Electrical Industry Compliance Audit and the AFL accreditation program. An unprecedented level of  activity providing immediate  revenues for set up and increased annuities to secure the future.

The Virtual Business Advisor www.virtualbusinessadvisor.nz has in the short time since launch helped thousands of organisations and sports clubs and is now able to deliver data on the strengths and weaknesses of whole business communities.“ For the first time we are truly able to understand the risks and constraints to growth of the entrepreneurial ecosystem” says Lyn Hay the Chairman of the Australian Innovation and Incubation Association and the CEO of the Adelaide business Hub.

QLBS is preparing itself for investment interest later in the year.

ABOUT QIMONO 

Qimono is a unique cloud platform that provides Advisory Services to the millions of small businesses. Our Business Advisory applications collapse cost and extend reach to small business and offer affordable advice for performance improvement. Shared knowledge through reports, benchmarks & dashboards capture ”Big Data” on the needs and trends of small businesses.

10 years in the making, Qimono is managed and owned by experienced ex-execs of Apple, IBM & Microsoft, who have done numerous start-ups.

STARIN FY16 Update; Over $12M Raised, Development Application Approved, New Branding, Expansion Continues

STARIN is kicking off the new financial year with the approval of the Development Application (DA) for the Macquarie Park Apartment Hotel Development. We have proudly raised over $12m and continue to steadily raise capital. We are in line for senior finance approval for up to $40m from a major bank. Most excitedly in 1 months’ time we have planned to be breaking ground with start of early works to commence in August 2016. STARIN has also had a facelift, with the introduction of a new logo and branding as well as a new website to improve communication with our growing investor community.

Key Milestones

As our 2016 financial year draws to a close, here’s a short summary of milestones achieved along with news of some exciting times ahead as we continue to secure our investment project at Macquarie Park Business Centre.

  • On 19th April 2016, the Development Application (DA) was approved for what is to be an iconic $55 million building in Macquarie Park.
  • The project, now with DA approval, is set to commence construction in August 2016. To lead the project during construction phase are prominent project management firms RPS Project Management and BlueVisions. This is a very exciting and long-awaited stage of the journey for Starin which continues to welcome new investors and well as nurture the confidence of existing investors.
  • Tenders are being evaluated and a contract for early works and main works is currently underway.
  • Ahead of construction, design of the building will be completed at 100% to ensure project timeline is kept, quality is maintained and cost escalation is minimised.
  • The equity raised for the project is over $12 million and senior finance of up to $40m has been lined up from a major bank. We are aiming for a loan of 50% LVR to minimise risk. The equity is being raised steadily and is moving forward.
  • An agreement is underway to have a reputable hotel operator manage the development.
  • We have a growing team of reputed consultants that are finalising the project design for Macquarie Park Hotel Apartments project with extensive experience and innovative strategies that will see the first tallest and most iconic building in Macquarie Park development by end of 2017.
  • Starin’s existing serviced apartments in North Shore Sydney, will grow from 28 rooms to a 100 room 3 star hotel. The expansion is progressing and a project plan is currently being developed.
  • New branding and a new website with social business channel that transparently communicates our investment projects and opportunities. Watch this space for further updates into the digital business arena.

ABOUT STARIN

STARIN Group is a specialist funds manager that actively engages in prime commercial property within the thriving hospitality and health care sectors, with $30 million in its management.

At STARIN, our committed approach to property investment is to produce quality, long-term consistent results for its investors by ensuring our projects deliver excellence and exceed expectations. Through our philosophy of “set, forget and enjoy life” we aim to look for the opportunities that will build your success as investors.

STARIN’s ongoing strategy is driven by a commitment to value its investors, build our model around our clients’ needs and deliver an outstanding service.

WYZA FY16 Update; $1.73M Raised, 12 Strategic Partnership Agreements & Research Survey Results

FY2016 Highlights: 

  • Raised $1.73 million.
  • After a name change to WYZA.com.au, (from Retirement Living.TV) in mid-2015 WYZA has grown at an extraordinary pace building our subscriber database to 200,000 (86% increase), Unique Audience to 370,000 (38% increase), Page Views to 1,000,000 (51% increase), Facebook to 24,100 (31% increase).
  • Entered into 12 strategic partnership agreements.
  • Filed WYZA trademarks in 9 classes and secured global domains
  • Surveyed nearly 8,000 of 200,000 subscriber database to determine our audience buying intentions in the next 12 months
  • Participated in the Vinnies CEO Sleepout raising over $23,000 for homeless and was awarded the ‘Most Innovative Fund Raising Award’.
  • Launching WYZA TRAVEL in next month.
  • Currently raising $750,000 through convertible notes to continue to grow the business pre major liquidity event anticipated in 2017.

ABOUT WYZA

WYZA is Australia’s fastest growing digital platform created specifically for people 50+. WYZA is disrupting the $200 billion spending patterns of the powerful 50+ demographic. A trusted destination that provides relevant and actionable information to help people 50 and over live their best tomorrow.

To download WYZA’s Research Survey please click on the button below. 

 

Folkestone Acquires First Asset for Seniors Living Platform

7th July 2016, ASX Announcement

Folkestone’s (ASX:FLK) real estate funds management subsidiary, Folkestone Real Estate Management Limited (FREML), announced today that it had exchanged contracts for the acquisition of Watermark Castle Cove, an award winning retirement living community on Sydney’s lower north shore, the first asset for its seniors living platform and the Folkestone Seniors Living Fund No. 1 (FSLF).

The acquisition of the Watermark Castle Cove retirement living community comprises:

  • a 100 per cent interest in 50 existing independent living apartments (ILAs) and ILAs undr construction which will be paid for on completion (including leasing); and
  • a 100 per cent interest in adjacent land for development of an additional 21 ILAson terms whereby part of the consideration is contingent on completion and leasing of the ILAs and the development is undertaken in a 50/50 joint venture with the Watermark Partnership.

To view the full announcement, please click on the button below.

OncoSil Medical to Attend 48th European Pancreatic Club Meeting

6th July 2017, ASX Announcement

OncoSil Medical Limited (ASX:OSL) (OncoSil Medical or the Company) a late stage medical device company focused on localised treatments for patients with pancreatic and liver cancer, today announced that a team of senior management would be attending the 48th European Pancreatic Club (EPC) in Liverpool, England.

The European Pancreatic Club meeting hosted by EPC President, Professor John Neoptolemos is focused entirely on pancreatic diseases and pancreatic cancer, making it one of the key international Scientific meetings for the Company to attend. This year the EPC meeting will run form 6 to 9 July 2016 and will host over 80 invited speakers from across Europe, the United States, Asia and Australia.

To view the full announcement, please click on the button below.

Omni Market Tide Appoints New CFO and Company Secretary

6th July 2016, ASX Announcement

Omni Market Tide (Company or OMT, ASX: OMT) is pleased to announce that Mr Stephen Kelly has been appointed as Chief Financial Officer (CFO) and Company Secretary of OMT. Mr Oliver Kidd has resigned as Company Secretary and Chief Operating Officer, and a transition process is underway.

Mr Kelly has strong experience across many sectors, working as a listed company CFO, Company Secretary and Executive Director for emerging companies on the ASX, London Stock Exchange, London AIM and Toronto Stock Exchange. Mr Kelly currently provides consulting CFO and Company Secretarial services to ASX listed companies and private companies.

ABOUT OMNI MARKET TIDE

Omni Market Tide is the market leader in digital stakeholder engagement. Omni Market Tide has a stakeholder engagement app designed to enhance the interconnectivity between company and stakeholders, allowing push communications, web streaming and direct voting, among other features.

To view the full announcement, please click on the button below.

YPB’s Executive Chairman John Houston interviewed by PeakTV

6th July 2016, ASX Announcement

YPB Group Limited (ASX:YPB) Executive Chairman John Houston has been featured in a new interview by PeakTV, filmed by Melbourne-based investment house Peak Asset Management.

The interview discusses how the YPB business has evolved since its IPO, the traction it is achieving in various overseas markets, the recently announced partnership with Orora and the earnings YPB expects to achieve in 2017.

To view theinterview, please click on the button below.

To view the full announcement, please click on the button below.

SUDA FY16 Update; Several Patents Granted Internationally, Strong IP Portfolio, Operation and Staff Expansion

SUDA LTD made steady progress with its pipeline of OroMist® oral sprays in FY2016. This included finalising the design of a pivotal PK trial and meeting with the FDA regarding the Company’s SUD-001 sumatriptan oral spray for the treatment of migraine. During the financial year, SUDA was granted several patents in the US, Canada and other territories, strengthening its IP portfolio.

The Company is advancing towards its business development goals to out-license its first-in-class oral sprays to pharmaceutical companies across the world. Discussions with prospective partners span its treatments for malaria, insomnia, migraine, nausea, and erectile dysfunction, as well as the application of SUDA’s OroMist® technology to new compounds.

The Company’s operations have expanded in 2016 with the addition of new staff. SUDA also took full control of its novel sublingual antimalarial ArTiMist™ with the acquisition of the 20% minority shareholding in its subsidiary company, Malaria Research Company Pty Ltd (MRC).

SUDA anticipates that FY2017 will be an exciting year for the Company with the prospect of securing several commercial deals and creating significant shareholder value.

ABOUT SUDA LTD

SUDA Ltd (ASX: SUD) is a drug delivery company focused on oro-mucosal administration, headquartered in Perth, WA. The Company is developing low-risk oral sprays using novel formulations of existing pharmaceuticals. The many potential benefits of administering drugs through the oral mucosa (ie: cheeks, tongue, gums) include ease of use, lower dosage, reduced side effects and faster response time.

SUDA’s product pipeline includes first-in-class oral sprays for insomnia, malaria, migraine, nausea and vomiting, erectile dysfunction and pre-procedural anxiety.

Anteo Diagnostics Ltd Acquires DIAsource ImmunoAssays SA & Other Highlights

6th July 2016, Anteo Diagnostics

Revenues of €14.171M in CY15 growing at greater than 10% per annum
DIAsource provides a strong platform

Other highlights from the past 12 months include:

  • Filed two new patents in battery (energy) space 
  • Appointed new distributors, including Sigma Aldrich
  • Successful trip to Tokyo Battery Expo yielded strong interest with global battery companies
  • Appointed Dr Jef Vangenechten Global CEO and Mr Rolf Sickman to the Board
  • Collaborating with Cook Medical on medical devices
  • Awarded funding for the development of a new rapid blood test for heart attacks in partnership with Atomo Diagnostics

ABOUT ANTEO DIAGNOSTICS

Anteo Diagnostics (ASX: ADO) is a global medical technology company, developing and commercialising products for sale into the lifesciences, in-vitro diagnostics, point of care, medical devices and bioseparations markets.

Spotlight Reporting FY16 Update; International Expansion, Strong Investor and Major Customer Interest

Spotlight Reporting has in recent months continued it’s three-figure percentage growth trajectory and expanded it’s teams in Australia, New Zealand, the UK and the US.  Investor and major customer interest has been strong, with Spotlight Reporting now providing forecasting, reporting and dashboard tools for three of the Big 4 accounting brands as well as numerous others in the Xero and Intuit communities.

Product releases made or in final stages of release include improved multi-currency consolidation (including eliminations), Board pack PDF insertions, and enhancements to our 3-way Forecasting tool.  These will be highlighted at Xerocon South (Brisbane) in September.

SPOTLIGHT REPORTING 

Spotlight Reporting is an innovative SaaS business intelligence reporting company. Our family of four products import data from leading financial and non-financial software applications to automatically create powerful management reports, dashboards, forecasts and multi entity reporting – saving time and effort while also delivering insight and clarity for accountants and business owners. The world’s largest accounting brands use our software, as do thousands of organisations across 40 countries.

Analytica FY16 Update; Successful $2.4m Capital Raise, R&D on PeriCoach® System, International Case Studies Published

Analytica has had a productive 2016, including a successful $2.4m capital raise with a cornerstone investment from Innov8 LLC, and the appointment of Dr. Thomas Lönngren to the Board.  The company is driving R&D work on the PeriCoach® System, aiming to provide game-changing functionality by the end of 2016.  Case studies have been published in the internationally-recognised Urological Nurses Journal describing PeriCoach’s benefits.

The company is pursuing over-the-counter regulatory clearance in the US, where it is currently prescription-only.  Our AutoStart Burette product has also been authorised for use by Queensland Health for use in all public hospitals.

ABOUT ANALYTICA LTD

Analytica Limited (ASX:ALT) is an Australian medical device manufacturing and commercialisation company. Its lead product, the PeriCoach System, is a novel medical device to treat stress urinary incontinence (SUI) – a condition with significant unmet medical need and huge market potential.

PeriCoach is a medical device that measures the muscles that matter when treating stress urinary incontinence and increases pelvic muscle strength.

Martin Aircraft Company FY16 Update; Technical Milestones Met, Successful Demonstrations, First Shipments Expected by End of 2016

6th July 2016

During the past year Martin Aircraft Company has met our technical milestones and continues to deliver value to stakeholders. On 6 December 2015 at Shenzhen China, in front of a crowd of 2,400 VIPs and distinguished guests, Martin Aircraft Company in collaboration with KuangChi Science successfully flew a manned and unmanned demonstration of the P12 Martin Jetpack.

The company was also hosted by the Dubai Civil Defence at Intersec 2016 and took centre stage at DefExpo, India, in April. Our attendance at the Top Marques Supercar Show in Monaco in May has attracted a significant number of Personal Martin Jetpack enquiries.

Production processes for the build of the P14 prototypes and Series 1 aircraft are currently being finalized with shipments to our first customers expected by the end of 2016.

TEHO International Opens New Stock Point in Algeciras, Spain

6th July 2016

TEHO is pleased to announce the opening of a new stock point in Algeciras, Spain, adding yet another strategic location for our customers to pick up our MAGNARO®-Float mooring rope and tails.

Algeciras is the latest addition to our global supply network that already encompasses SINGAPORE – ROTTERDAM – DUBAI – HOUSTON – SHANGHAI. These key ports enable customers to source the same quality and type of ropes, and enjoy the peace of mind that comes from avoiding mixed mooring on their vessels.

Steel wire ropes, environmentally friendly (EAL compliant) lubricants and rigging accessories are also stocked in Rotterdam, Singapore and Houston.

Crowdfunding Start-Up DomaCom Eyes $100m ASX Float

5th July 2016, The Australian By Ben Wilmot

DomaCom, the company that shot to prominence with a crowdfunding campaign to acquire the property assets of the iconic Kidman Station empire, is looking to float as a near $100 million company on the Australian Securities Exchange.

The ambitious group is hoping to ride the worldwide popularity of crowdfunding which it has used to set up real estate funds and it plans to extend its reach into the corporate bond market and equity release products.

Company founder, Arthur Naoumidis, who also set up the now listed portfolio technology provider Praemium, had previously flagged plans to raise $100m through a float last year but the timing of the IPO was pushed back.

DomaCom instead sought to raise up to $20m from wealthy investors and bulked up as a company that will be unique on the bourse and could make Mr Naoumidis one of the biggest winners from the crowdfunding craze.

To view the full article, please click on the button below.

iCompLii Investor Update: Results of Initial Trials, New Sales and Marketing System, Competition & Rights Issue

Results of Initial Trials

At the beginning of 2016, we carried out a very successful three month trial period. During that time, we did a small amount of marketing via our websites and social media channels to encourage the audience to create an iCompLii profile. In just 3 months we had over 16,000 individual profiles created.

In that initial trial we monitored various aspects of the onboarding process, and the progression of people signing up to create a profile. Through monitoring we have found and taken steps to build on the positive trends, and quickly update to improve the process even further. We also uncovered a few minor deficiencies whilst carrying out the quality checks, which were quickly rectified.

With each new business that signs up we are fine tuning the advertised features and benefits, and in turn the value proposition for our target clients. We have been able to tailor sales strategies and more importantly, continually improve what companies react most favourably to in their sales pipelines. We have now released the first customised landing pages for companies, allowing these companies to build their own talent communities. This has been a successful value add to our business clients already using the compliance tool.

We have now connected several hundred workers to employers and know that several dozen of these connections have resulted in part time and permanent placements. This success has placed us nicely in front of the media. iCompLii has been showcased in several newspapers and we were invited to a radio interview for the great work we are doing to help people back into the workforce, whilst lowering the cost of organisations doing business.

New Competition

Traditional recruitment and cloud based HR tools is a very busy space. For most of our journey in the recruitment space there has been very little evidence of any direct competition, but we knew it couldn’t be too far away.

In Q3 of 2015 iCompLii started marketing to begin building the iCompLii brand, and since that time several other competitors have also stuck their heads out of the sand. The interesting thing to note here is that each competitor is doing only an aspect of what iCompLii is doing, but none have put it together in a single suite. None of these competitors are creating a truly portable profile, which is where the biggest value is to a business, reducing administration and compliance burdens.

Personnel Management Sector Update

In recent months we have witnessed some exciting and successful events in our sector -

  • LiveHire has successfully listed on the ASX with a $10m capital raise and a $40m valuation

(LiveHire’s platform is similar to just one part of the iCompLii platform, the talent pools.)

  • TikForce successfully raised $4.5m in a reverse takeover of Palace Resources, with a valuation a little over $10m (TikForce has a platform similar to iCompLii’s compliance section)

And the big one -

  • Microsoft has acquired LinkedIn for a bit over $26 billion.

The success of TikForce and LiveHire suggest that the public market is ready for platforms like iCompLii; validation that iCompLii is on the right track. Whilst both LiveHire and TikForce are reporting they are in revenue, they are at a very similar stage to iCompLii with enough clients to prove concept only.

The acquisition of LinkedIn is one of many acquisitions in the social media and user database sector, and it is exciting because it shows that larger companies are hungry for user information. To our knowledge, iCompLii holds far more sophisticated and structured data than many of the other companies being acquired.

New Sales and Marketing System

On the 1st of July we rollout the trial of the new sales and marketing system, which is a hybrid of traditional sales system and multi level marketing. This new iCompLii sales and marketing system will return an average of 38% of all sales revenue back to the compensation plan, which also means that iCompLii has a fixed cost of acquisition, and retains 62% of sales revenue.

Another positive is that, via independent consultants, iCompLii can reach workers and candidates faster, meaning that the new sales and marketing system is covering both sides of the market place. We are also expecting a greatly reduced commercialisation cost through the hybrid sales and marketing plan.

Not everybody was reachable in late May when we were gauging interest and opinions of the new sales and marketing plan. So, if you were one of the people that has not been given more detailed information, your iCompLii contact will get in touch during July to find out if you are interested in receiving commissions for referring candidates and businesses to iCompLii.

Technology

iCompLii has finalised the first stage of our iOS native app and has been lodged with apple, and should be available in next month or two for download, the App is free to download and will be a value add to the iCompLii community. The Android app is now in development and will be ready for testing in a few week

These native phone apps are going to lower the barrier to entry for and non-technical people, and already have the following capabilties

  • Point and shoot simplicity with the camera to get documents into iCompLii
  • Messaging capability built in where you can message your connected friends and communicate with iCompLii for assistance,
  • The app keeps your basic details at you finger tips, like;
    • iCompLii ID
    • Connect Pin ( you need this toenable connecting to businesses )
    • TFN
    • Super details
    • USI

iCompLii has entered talks with with both encryption technology companies, Block chain and AI technology to machine read all credentials loaded into the system, These talks are progressing well and in some cases we have already come to agreements that just require formalisation

Rights Issue

We are now initiating the next stage of fund raising. As you know, the Board had proposed to open a $1.5m dollar Series A raise earlier in the year. Due to a successful application of R&D funding for financial year ending 2015, and acceptance of our project for additional R&D funding in the current financial year, the Board of iCompLii has decided to do a much smaller raise.

The current fund raise is open as of today 28th of June 2016, where we intend to raise $510,000 through the sale of 3,000,000 new shares via an offer that is a Rights Issue. The Rights Issue entitles each of the existing shareholders the opportunity to purchase an additional 1 share for each 15.8 shares you currently own, at a price of 17c per share.

The purpose of a Rights Issue is to give first option to existing shareholders so that post fundraising, your current holding in the company is not diluted. New and existing shareholders will be given the opportunity to purchase shares that are not taken up in the Rights Issue. If we receive a great deal of interest in the Rights Issue, the Board will consider whether or not to issue additional shares at the Rights Issue price to meet over subscriptions.

Omni Market Tide Appoints New CEO

5th July 2016, ASX Announcement

Omni Market Tide (OMT or the Company) announces today the departure of Megan Boston as Managing Director of OMT.

Over the past year, OMT has achieved a number of milestones with Megan as Managing Director, such as, on 30 May 2016, OMT became the first company in Australia to hold a digital and real time Annual General Meeting using its digital enterprise solution OmniLOOP. Mrs Boston executed the alignment of OMT’s technology with Boardroom registry Australia, and then extended that alliance into Singapore and Hong Kong. Under Mrs Boston’s leadership, the Company executed engagement agreements with Telstra and Westpac, OMT’s two major clients, and delivered a number of engagement platforms including OmniLOOP.

The Board takes this opportunity to thank Megan for her service.

OMT’s New Chief executive Officer – Steve Terry

As such, we are pleased to announce the immediate appointment of Steve Terry as Chief Executive Officer. Steve has outstanding executive leadership skills and experience in technology, and driving new sales revenue in new markets. Steve is a visionary and pragmatic senior thought leadership executive with 20 years’ experience in operational management across the Asia Pacific Region within the technology industry.

Prior to joining OMT, Steve spent the last six years working as the General Manager for the Queensland operation of TechnologyOne Limited (ASX listed). Headquartered in Queensland, TechnologyOne is Australia’s largest enterprise software company with a $1.5 billion market capitalisation.

To view the full announcement, please click on the button below.

DeClout Performance Share Plan

4th July 2016, DeClout

Unless otherwise defined, all terms not defined herein shall be as defined in the rules of the DeClout Performance Share Plan (“DeClout PSP”).

In accordance with Rule 704(32) of the Listing Manual Section B: Rules of Catalist of the Singapore Exchange Securities Trading Limited (the “SGX-ST”), the board of directors (the “Board” or “Directors”) of DeClout Limited (the “Company”, and together with its subsidiaries, the “Group”) wishes to announce the grant of share awards (“Awards”) to the Participants (being employees of the Group) pursuant to the DeClout PSP.

To view the full article, please click on the button below.

Booodl: Store Discovery Optimisation & The Future of Search

Store Discovery Optimisation

As you may know, we created a content hub around Store Discovery Optimisation dedicated to helping the physical retail ecosystem thrive. This concept and the technology underpinning it are so important for helping retailers drive shopper visits, increase sales, and defend against Amazon. We’re ready to get our microsite out there and share it with the world. Will you help? Visit the site, share the content and sign up to our SDO newsletter.

Read more.

Who will win search?

We also wanted to share our latest post on the future of search, what role Google will play in it, and the impact on physical retailers. Have a read and let us know what you think!

Read more. 

 

UnionBank Proposes User Increase from 50, 000 to 2, 500, 000 for Peppermint

30th June 2016, ASX Announcement

Highlights:

  • UnionBank to increase account holders registered on the UMobile mobile banking platform deployed with the Bank by Peppermint.
  • Ramp up from 50,000 to 2,500,000 registered users on UMobile.
  • Significant increase expected in monthly transactions across the platform.

Peppermint Innovation Limited (ASX: PIL) is pleased to advise UnionBank of the Philippines (“UnionBank”), which uses Peppermint’s platforms to offer mobile banking services to its account holders via the UMobile application, has proposed to significantly increase registered users across this platform.

UnionBank confirmed that it is intending to register a further 2.5 million account holders on  UMobile application starting in July, under the batch enrolment feature of the app.

To view the full announcement, please click on the button below.

Alcidion’s CMO to Present at Health Informatics Conference

1st July 2016, ASX Announcement

Highlights:

  • Professor Malcolm Pradhan to present at Health Informatics Conference.
  • Alcidion to unveil “Deep Learning” Product Roadmap Strategy for Patient Flow.
  • Technology incorporates predictive analytics to streamline Patient Flow.

Alcidion Group Limited (ASX:ALC) is pleased to announce that Professor Malcolm Pradhan, Alcidion’s Chief Medical Officer, will present a paper on “Deep Learning for Patient Flow Prediction” at the Health Informatics Conference (HIC) on July 25th 2016.

Deep learning is a branch of Machine Learning based on recent advances in neural network technology that has enabled computers to achieve better than human performance in tasks such as image recognition.

To view the full announcement, please click on the button below.

Catcha Group Partner Bulletin July 2016; Patrick Grove Talks to Bloomberg Malaysia, iflix Expansion & Wild Digital Video Presentations

Patrick Grove: Growth of Internet Firms Just ‘Beginning’

Bloomberg TV Malaysia
Patrick Grove talks to Bloomberg TV Malaysia, saying the potential to have more successful Internet-related companies is “almost unlimited” with the sector taking up only 10% of global market cap.
Watch here

iflix Expands From Southeast Asia Into Frontier Markets

The Australian
iflix chief executive Mark Britt says the digital streaming company is on track to become a multi-billion business, as it looks to expand from its Southeast Asian base into frontier markets such as Africa and the Middle East.
Read more

Australian media seen as missing opportunity of Asia growth
The Australian · Read More

Entrepreneur, industry leaders stress on passion, perseverance at conference
Straits Times · Read More

We completely f**ked up in our first 8 years: Catcha’s Patrick Grove
Digital News Asia · Read More

iflix aims for Africa, Middle East markets, after taking on Indonesia
Deal Street Asia · Read More

iflix boosts NBCU content library
Media Business Asia · Read More

Frontier Digital Ventures appoints Shiao Chan as CFO
Digital News Asia · Read More

Click here for the full list of all video presentations from Wild Digital 2016.

Unity Pacific Settlement of 308 Queen/88 Creek St & Distribution Update

30th June 2016, ASX Announcement

Unity Pacific Limited (ASX: UPG) (Unity Pacific) announces that the sale of 308 Queen Street / 88 Creak Street, Brisbane (the Property) has settled today.

The sale of the Property has resulted in a profit of $2.1 million after transaction costs. Please refer to Unity Pacific’s announcement of 17 June 2016 for further information.

Distribution of Property Sale Proceeds

Unity Pacific has applied $12 million of the net proceeds from the Property sale to fully repay its debt facility.

To view the full announcement, please click on the button below.

Universal Biosensors Appoints Craig Coleman as Non-Executive Director

30th June 2016, ASX Announcement

Universal Biosensors, Inc (ASX: UBI) today announced the appointment of Mr. Craig Coleman as a non-executive director to the Board of Universal Biosensors. This appointment continues the board renewal process which has occurred over recent years, with the appointment of Ms. Judith Smith in 2015 and Mr. David Hoey in 2016.

Mr. Colemans career of 30 years has spanned banking and finance, corporate advisory and funds management. During his executive career, he has been a Managing Director of a publicly listed company (Home Building Society Ltd) and prior to this, held a number of senior executive positions with ANZ Banking Group Ltd, including Managing Director Banking Products, Managing Director Wealth Management, Non-Executive Director E*TRADE Australia Ltd and Head of Retail Banking New Zealand.

To view the full announcement, please click on the button below.

OncoSil Medical Regulatory Update June 2016

30th June 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical or the Company) a late stage medical device company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to provide an update on its regulatory submissions.

European Union – CE Mark 

The Company advises that in May 2016, it submitted further material in support of its CE Mark application for the OncoSil™ product in response to all requested questions received from the Notified Body, BSI, which is assessing the submission. Since then, no additional follow up questions have been received from BSI.

The Company remains confident of a successful outcome in its CE Mark which it believes could be in the near term, thus enabling to commencement of commercial sales of OncoSil™ in the European Union and application for commercialisation in Asia Pacific markets.

To view the full announcement, please click on the button below.

BPS to Offer Insurance Products Channel

30th June 2016, ASX Announcement

BPS Technology Limited (ASX:BPS) will partner with leading Australian insurance broker, Honan Insurance Group, to offer insurance products from a select group of global insurers. The goal of BPS is to offer via its platforms competitively priced and tailored business insurance packages to its vast SME merchant base. The insurance products, including business and travel insurance, are designed specifically for various  categories of business.

This offering continues BPS’s focus on Channel Enablement as a way to deliver an increasing range of products and services to its 24,000 SME base from which BPS can earn additional low cost revenue.

To view the full announcement, please click on the button below.

iFAST Complete Sale of a 5% Stake in iFast China Business For USD1.75 Million

29th June 2016, iFAST Corporation

The Board of Directors (the “Directors” of the “Board”) of iFAST Corporation Ltd (“iFAST” or the “Company” and together with its subsidiaries, the “Group”) refers to the Company’s announcement dated 28 April 2016 (the “Previous Announcement”) in relation to the entry by its subsidiary, iFAST China Holdings Pte. Ltd. (formerly known as  FA Corporate & Compliance Consultancy Pte. Ltd.) (Company Registration No. 200722799G) (“iFAST China Holdings”) into a non-binding memorandum of understanding (the “Memorandum”) with Caerulean Limited (BVI Company No. 190290) (“CL”) with its registered address at c/o Offshore Incorporations Limited, P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands (collectively, the “Parties” and each, a “Party”.) The Board wishes to announce that the following Memorandum, the Parties had, on 29 June 2016, entered into subscription agreement (the Agreement).

Pursuant to the Agreement, CL shall subscribe for, and iFAST China Holdings shall issue and allot, 78,948 newly issued ordinary shares in iFAST China Holdings (the “Subscription Shares” and each, a “Subscription Share”), representing 5% of the share capital of iFAST China Holdings on an enlarged basis, at a cash consideration of US$1.75 million (the “Subscription Consideration”) arrived at on a willing-seller and willing-buyer basis (the “Subscription”). The Subscription has been completed today in accordance with the terms and conditions of the Agreement and the Subscription Consideration has been satisfied in full in cash on date of completion (“Completion”).

To view the full announcement, please click on the button below.

Peppermint Announce MyWeps Remittance Licence Grant by Philippines Central Bank

29th June 2016, ASX Announcement

Peppermint Innovation Limited (ASX: PIL), an Australian mobile banking, payments and remittance technology platform focused on providing vital access to to banking services for millions of people not currently linked to traditional banks, is pleased to announce the grant of a remittance licence to MyWeps for the mobile payments and remittances application developed and powered by Peppermint in the Philippines.

The MyWeps App is now available on Google Play initially to the 1Bro Global agent network, which consists of up to 90,000 agents and 40 business centres across the Philippines, prior to other agent networks, co-operatives and similar organisations identified as suitable proponents of the platform.

To view the full announcement, please click on the button below.

ThinCats Investor Update June 2016; Over $3m Loaned, Over 300 Registered Lenders & New Website

As our 2016 financial year draws to a close, here’s a short summary of milestones achieved along with news of some exciting times ahead as we cement our position as the leading Peer-to-Business (P2B) Lending Platform in Australia.

Key Milestones

  •  Over $3m (25 loans) to a diverse range of SME borrowers and a pipeline forecast to grow our loan book to over $20m (100 plus loans) within 12 months.
  •  Over 300 registered Lenders (wholesale investors and Self-Managed Super Funds) receiving an average yield of 13.8% p.a. on loans secured by business assets, mortgages (in some instances) and personal guarantees of directors – zero default on loans since inception.
  •  The average direct loan size per lender, per loan, is over $7k, meaning that a loan for $200k would generally be financed by up to 30 lenders, each making a direct decision to lend after evaluating all loan information, financials, and borrower credit checks, all transparently provided on the platform. It’s pure P2B lending, as ThinCats do not earn a margin spread, with lenders receiving all the interest paid by borrowers on the platform.
  •  A number of alliances with loan referral sources, including over 100 finance brokers and accountants to refer loans, and leading edge technology providers.  This enables us to automate our processes, improve credit analytics and ultimately better serving borrowers and lenders.
  •  A $30m funding arrangement (over 2 years) to part finance selected larger loans, with our JV partners ThinCats/ESF, who enter their 6th year of operations with over $400m in loans making them a leading P2B lending platform in the UK.
  •  A larger and stronger Australian sales, digital marketing, finance and administration team with over 100 years of combined senior banking and lending experience, positioned to meet future business growth needs.
  • A new website with social business channel that transparently communicates our differentiation from all other market place and non-bank lenders. Watch this space for further updates into the digital business arena.

Our values and skill sets place ThinCats in a unique position where we squarely focus on the least serviced segment of the SME borrower market, profitable SME’s looking for growth finance (loans over $100k) over longer terms (up to 60 months) at competitive rates (up to 16% p.a.). These businesses are “bankable” but cannot raise funding from their bank as they have run out of homes to offer as security.

Generally other market place and non-bank business lenders provide quick turnaround, short-term (< 12 months) small loans (under $100k) at high interest rates (up to 80% p.a.) on an unsecured basis, servicing an entirely different segment of SME borrowers.

As a final note, your support as founding customers to date has been invaluable to us and we thank you sincerely for this. We would also greatly appreciate you continuing to help us grow brand awareness of ThinCats across Australia, as a truly unique business lending platform. Our Twitter handle is @thincatsAUS and you can easily search and follow us on LinkedIn as we amplify and grow our online brand presence with a large boost planned by our new CMO starting 1 July.

Crowd Mobile Enters into Agreement to Refinance Debt

30th June 2016, ASX Announcement

Highlights:

  • Crowd Mobile refinances its term debt with a new €10.80m (AUD$16.12m) facility at a significantly reduced interest rate of 6.25% (compared to previous rate of 12%).
  • The new Facility provides additional funding to assist with growing the business and drive marketing initiatives.
  • The Track Vendors have agreed to an extension to their consulting agreements and a 12-month extension to the vendor loan payment to October 2017.
  • The business continues to perform materially in line with the March 2016 quarter.

Crowd Mobile Limited (ASX: CM8 & FWB-XETRA: CM3, “Crowd Mobile”, or “the Company”) is pleased to announce that it has secured a senior secured convertible note facility (“Facility”) from a leading US based fund manager (“Lender”) to replace the Company’s existing senior loan facility from its European debt provider. The Company will seek shareholder approval at an Extraordinary General Meeting (“WGM”) to complete the refinancing which is expected to be held on 1 August 2016.

To view the full announcement, please click on the button below.

 

Major Biopharmaceutical Signs to Up to MedAdvisor Patient Engagement Program

1st July 2016, ASX Announcement

Highlights:

  • MedAdvisor is collaborating with Bristol-Myers Squibb Australia (BMS) to deliver a patient engagement and education program concerning one of its products
  • Commencing shortly the 12-month patient engagement program (PEP) is being delivered via MedAdvisor’s medication management platform
  • This agreement will generate further PEP revenue for MedAdvisor
  • Provides further strong validation for MedAdvisor’s platform from a leading global biopharmaceutical company

MedAdvisors Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it will be collaborating with the Australian subsidiary of leading global pharmaceutical company, Bristol-Myers Squibb Company, to deliver a new patient engagement and education program.

To view the full announcement, please click on the button below.

Folkestone Education Trust Debt Facility and Fund Update June 2016

30th June 2016, Folkestone

On 30 June 2016, Folkestone Education Trust (“FET”) successfully refinanced its $227 million debt facility with Australia and New Zealand Banking Group Limited (“ANZ”) and Hongkong and Shanghai Banking Corporation Limited (“HSBC”).

The new bilateral facilities extend FET’s debt finance tenure to an average of four years. Key covenants regarding LVR and ICR remain unchanged.

ABOUT FOLKESTONE

Folkestone is an ASX listed real estate funds manager and developer which offers listed and unlisted funds to investors. The Company generated a net profit after tax of $7.1m in FY15, an increase of 122.6%, recorded strong growth of more than of 12.8% to $917m FUM and a development pipeline in excess of $1.0bn.

Folkestone manages the Folkestone Maxim A-REIT Securities Fund a high conviction, actively managed fund that gives investors exposure to a mix of quality listed A-REITs that own assets across the retail, residential, commercial, hotel, industrial and real estate related social infrastructure sectors. The Folkestone Maxim A-REIT Securities Fund was the best performing fund in the Morningstar Australian Institutional Sector Survey in FY15.

To view the full announcement, please click on the button below.

YPB Takes First Step into Pharmaceutical Industry

1st July 2016, ASX Announcement

Highlights:

  • Three-year supply contract with Universal Pharmaceuticals Ltd for the provision of YPB’s anti-counterfeit and consumer engagement technologies
  • Universal Pharmaceuticals – Australian company exporting pharmaceuticals products to growing Chinese and South East Asian markets
  • Reflects greater awareness of potential counterfeit issues in the Australian pharmaceutical industry and importance of brand protection

YPB Group Limited (ASX:YPB) has entered into a supply contract with Universal Pharmaceuticals, a NSW-based pharmaceutical company exporting quality pharmaceuticals to the rapidly-growing Asian market.

Under the contract YPB will provide its invisible covert tracer technology to Universal Pharmaceuticals.

To view the full announcement, please click on the button below.

TFS Finalises Sale of Part of Its Loan Book

29th June 2016, ASX Announcement

TFS Corporation Limited (“TFS”, ASX: TFC, “the Company”), the world’s largest owner and manager of commercial Indian sandalwood plantations, today announced the signing of agreements to sell a portfolio of loans and receivables advanced  to plantation investors and the commencement of on-going loan funding programs with two Australian based financiers.

Consistent with TFS’s established practice of periodically releasing capital by divesting loans issued to plantation owners, the Company has entered into agreements to sell loans and receivables with a book value of $25 million for cash proceeds of $24 million cash.

To view the full announcement, please click on the button below.

Actinogens’ Xanamem™ to Showcase Cortisol Hypothesis

29th Sydney 2016, ASX Announcement

Actinogen Medical (ASX:ACW) is pleased to announce the key data supporting its novel Alzheimer’s drug Xanamem™, has been selected by an independent expert panel for presentation at the world’s largest dementia research conference – the Alzheimer’s Association International conference (AAIC), in Toronto 22nd – 28th July, 2016.

The presentation entitled, “Xanamem™ a novel 188-HSD1 inhibitor with as potential to provide durable symptomatic and disease modifying benefits in Alzheimer’s disease“, will include results on Xanamem™’s succesful Phase I human trials and importantly confirm that following oral administration Xanamem™’s effectively crosses the blood-brain-barrier and gets to the brain, its primary site of action in Alzheimer’s disease.

To view the full announcement, please click on the button below.

MedAdvisor Sees Strong Growth in Key Business Drivers

29th June 2016, ASX Announcement

Highlights

  • Strong progress across key revenue drivers for the business:
    -Rapid acceleration in patient user growth, with approximately 18,000 patients now using  the platform, a monthly growth rate of ~10% (vs. 6% in March Qtr.)
    - Substantial pharmacy network expansion,  with over 1,600 pharmacies now in the network, encompassing over 30% of all Australia’s community pharmacies
    - The Company continues to grow its manufacturer client base for Patient Engagement Programs
  • Patients now ordering over $1 million worth of scripts refills each week through MedAdvisor pharmacies on our Tap-To-Refill script ordering function
  • Increasing validation of the Company’s value proposition to patients, their pharmacies and the broader health system

To view the full announcement, please click on the button below.

Global Institutional Investor Acquires New TFS plantations

28th June 2016, ASX Announcement

TFS Corporation Limited (“TFS”, ASX: TFC, “the Company”), the world’s largest owner and manager of commercial Indian sandalwood plantation, today announced the execution of contracts with a new institutional investor in the Company’s Beyond Carbon product. The new investor is a US-based global investment management firm with over US$100 billion of assets under management and an established track record of investing in Australian and New Zealand agriculture.

This transaction has been approved by the Foreign Investment Review Board.

To view the full announcement, please click on the button below.

Proteomics International Laboratories Board Changes

28th June 2016, ASX Announcement

Proteomics International Laboratories Ltd (ASX: PIQ) (the Company) announces that Dr Bill Parker and Mr James Moses have resigned as Directors of the Company.

Dr Parker was a founder of Proteomics International in 2001, and has made a long and significant scientific contribution to PIQ but steps down to ensure that the Board of Directors is of a size and composition that is suited to a company at PIQ’s stage of development. Dr Parker will continue to provide guidance to the Proteomics International management team in consultancy role on terms to be negotiated on an arms’ length basis.

To view the full announcement, please click on the button below.

BPS & Gruden Group Colllaborate

28th June 2016, ASX Announcement

Highlights:

  • BPS Technology and the Gruden Group will collaborate to deliver new and exciting mobile payments and loyalty platforms for a range of Australia’s leading consumer brands
  • Consumers to earn rewards which will redeemable with an extensive range of BPS’ 24,000 merchant clients
  • BPS and Gruden will earn fees on transactions executed via the platforms that arise from the agreement

Leading financial technology platform provider BPS Technology Limited (ASX:BPS, “the Company”) is pleased to announce it has executed a Marketing Services Agreement with the Gruden Group Ltd (ASX: GGL, ‘Gruden’).

Gruden is one of Australia’s leading digital marketing and transactional payment specialist companies in the quick service restaurant (QSR), leisure, hospitality and retail sectors.

To view the full announcement, please click on the button below.

Tasmania’s Northern Integrated Care Service Goes Live with Alcidion

27th June 2016, ASX Announcement

Highlights:

  • Tasmania’s Department of Health & Human Services goes live with Miya Clinic.
  • Provides a unified Electronic Medical Records for Outpatient Clinics.
  • Future potential integration into the National Personally Controlled Electronic Health Record (PC-EHR).

Alcidion Group Limited (ASX: ALC) has completed the deployment of Miya Clinic to the Northern Integrated Care Service for the Department of Health & Human Services in Tasmania, inclusive of integrating twelve months of historical patient data into the platform.

The system provides an integrated solution for Outpatient Clinics and is interfaced with Pathology and Radiology Systems (RIS/PACS), Administration System (PAS) and the Outpatient Booking system with integration into the Emergency Department Information Systems (TrakED) scheduled for later this calendar year.

To view the full announcement, please click on the button below.

Peppermint Innovations 2016 FY Achievements

27th June 216, ASX Announcement

As we look back on what your company has achieved during the 2016 financial year it is clear we have done a great deal, created an extremely strong operational and financial foundation and in the process created strong positive momentum.

While our stated aim is to provide mobile payments, money services and remittances to anyone, anywhere in the world, especially those not currently linked to traditional banks, it is important for you to know that our aim is actually a reality – you have invested in a real business, generating real revenue and having genuine partnerships with some of the largest players in our primary market, the Philippines.

Our Philippines operations are established and proven – and ready for significant growth. We have a secure and commercially deployed white label mobile banking and payments platform approved by key regulatory bodies with 100,000 subscribers performing circa 1.13 million transactions per month.

To view the full announcement, please click on the button below.

Martin Aircraft Company Investor Relations Presentation

24th June 2016, ASX Announcement

Corporate Overview

Mission: To build the world’s first practical Jetpack to save and improve human lives

Innovation: One of TIME Magazine’s Top 50 Inventions of 2010

Design: Eloquent engineering backed by unparalleled high-powered performance and robust aeronautics

Safety: Dedicated safety systems include a ballistic parachute system that can safely recover the aircraft from a few meters above the ground

Our Story – From Dream to Reality

1981 – The Martin Jetpack is the result of founder Glenn Martin’s dream conceived as early as 1981 to build the world’s first practical jetpack

1998 – Commercialisation of the Martin Jetpack began in 1998 with the founding of GNM Ltd, which became Martin Aircraft Company in 2008

2014 – At the end of 2014, the company signed a cornerstone agreement with KuangChi Science Ltd.

To view the full presentation, please click on the button below.

Real Estate Your Way Market Update June 2016

Following on from the presentation at the recent Wholesale Investor Conference in Sydney, Real Estate Your Way is pleased to say it has received strong interest from some highly credible sources including some ASX listed companies.

Real Estate Your Way is currently working through the process and is quietly confident that a deal will be reached soon.

ABOUT REAL ESTATE YOUR WAY 

Real Estate Your Way is a prominent “digital disruptor” property advertising website that is at the leading edge of a new trend in real estate advertising in Australia. The business is fully operational, has considerable intellectual property assets including the website, registered trademarks, social media following as well as registered domains that would be suitable for international expansion.

The company has an established relationship with a large mortgage broking firm and is an excellent opportunity for any Australian or overseas media business, financial services provider, real estate business or business migrant to gain quick entry in the rapidly emerging “For Sale By Owner” property advertising market. The owner is retiring and wishes to sell a majority stake.

To register your interest or make further enquiries please click on the button below.

Altech Chemicals Presentation at the 3rd International Sapphire Expo

23rd June 2016, ASX Announcement

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide a copy of the presentation that will be delivered by Company General Manager Operations, Mr Jingyaun Liu at the 3rd International Sapphire Industry Technology Exhibition (Sapphire Expo) in Shenzen, China on Thursday, 23 June 2016.

The Sapphire Expo is an annual trade show that is held over three days (22 – 24 June 2016) and attracts hundreds of sapphire industry participants from around the world. Participants include sapphire glass and wafer manufacturers, sapphire substrate producrers, high purity alumina suppliers, and importantly representatives from the LED lighting and lithium-ion battery manufacturing sectors.

To view the full presentation, please click on the button below.

BPS Investor Presentation Update June 2016

21st June 2016, ASX Announcement

BPS Technology Half year Highlights

  • Revenue of $25.1 million, exceeding prior corresponding period (H1FY15: $24.9 million)
  • EBITDA of $4.7 million, up  4% (H1FY15: $4.5 million)
  • Earnings per share of 6.0c, up 7.2% (HY15: 5.6c)
  • Interim dividend of 2.0 cents per share unfranked declared
  • New Sales Model resulted in 39% growth in new Merchants
  • Bartercard USA operations revenues up 124%
  • Acquisition of further 2 large franchises in Australia – over 70% of Members now managed by company owned sites
  • bucqi launched in 3 Queensland regional centres  with more than 200+ Merchants and 2,000+ Consumers participating
  • TESS delivered software to IRTA that saw record levels of trading recorded – highest ever achieved
  • Laid the foundation for growth for FY17
  • Executive directors and management team own 55% of issued shares
  • Well positioned to capitalise on various growth opportunities on our platforms

To view the full presentation, please click on the button below.

Universal Biosensors Business Update; Fast Revenue Growth, Unique Patent Protected Technology & New Product Development

21st June 2016, ASX Announcement

UBI: Investment Highlights:

  • Targeting the large and growing Point-of-Care Diagnostics market
  • Fast growth in revenues based on sale of disposable test strips
  • Validating the technology through partnering deals with LifeScan and Siemens
  • Unique patent protected technology with low cost manufacturing
  • Driving growth beyond the existing product platform via new product development

Strong revenue performance with record Quarterly Service Fees achieved 

  • Blood glucose monitoring : QSF generated from OneTouch® Verio® were $4.9m in Q1′FY16 (up 68% compared to pcp)
  • Blood coagulation monitoring : Xprecia Stride™ revenues were $183k in Q1′FY16 (up 154% compared to pcp)
  • Total FY15 revenues improved 76% compared to pcp to $16.8m

To view the full announcement, please click on the button below.

High Purity Alumina Demand Driven by Lithium-Ion Batteries

21st June 2016, ASX Announcement

Highlights:

  • HPA demand for lithium-ion battery manufacture forecast to increase at 30% per year to 2025
  • Demand forecast to increase from ~1,000tpa in 2016 to ~15,000tpa in 2015
  • Equivalent to four (4) of Altech’s proposed HPA plants required to satisfy 2025 demand
  • Electric vehicle manufacturers requiring lithium-ion batteries HPA coated separators

Following its 3 June 2016 announcement regarding the strong interest shown in Altech Chemicals Limited (Altech/the Company) (ASX: ATC) as an emerging high purity alumina (HPA) producer during the 12th China International Battery Fair, the Company is pleased to present its 10-year forecast of global demand for HPA used in the lithium-ion battery manufacturing sector.

To view the full announcement, please click on the button below.

Leaf Resources Investor Presentation June 2016

20th June 2016, ASX Announcement

Attached is the company’s new presentation detailing our proprietary Glycell™ process, the market opportunities for the process and projects we are currently developing.

Company Overview

Leaf Resources is a green chemical company that uses plant waste/biomass to create industrial chemicals to replace petrochemicals in manufacturing.

  • Patent pending Glycell™ process that converts plant biomass into industrial sugars (a key component used to create green/sustainable chemicals)
  • Large cost advantage over other processes that create industrial sugars
  • Glycell™ is well-suited for a low-carbon world as it is sustainable, carbon friendly and cuts carbon emissions

To view the full presentation, please click on the button below.

Invitation to Legado’s Private Capital Investments Early Stage Comment Round Table

New dates added for Sydney, Melbourne and now Brisbane. 

Legado invites you to attend an early comment forum with current and prospective investors.

This session is to provide you with an opportunity to gain insight into specific deals in our pipeline and share with us your perspective on the opportunities in front of us.

There are some very good private businesses for sale in Australia where you can buy them at much lower price than listed shares or large corporates. There are also some very good management teams who run these businesses, who need cash and resources to help with the transition for the current owner.

If you would like to attend one of our sessions please follow the below links to get your free ticket through Eventbrite.com. Spaces are limited to registering is esential.

Is Legado right for you? 

If you have investable funds of $500,000 or more, you invest for the long term, you seek outstanding returns of 20%+, and you have an understanding or an appreciation of business then you may be a good fit. Please contact our office for further information or to understand the investment options that Legado offers.

Canberra

Wednesday 20 July 2016,
4:00PM
Legado Office, Level 1,
113 Canberra Avenue, Griffith.

Register Now

Melbourne

Thursday 21 July 2016,
3:00PM & 5:00PM
Exchange Tower, 530 Little Collins Street, Melbourne

Register Now

Sydney

Wednesday 17 August 2016,
3:00PM & 5:00PM
Level 9, 55 Hunter Street, Sydney.

Register Now

Brisbane

Wednesday 21 September  2016,
3:00PM & 5:00PM
Brisbane CBD – venue to be confirmed.

Register Now

Tesserent Appoints Kurt Hansen as Head of Global Sales

20th June 2016, ASX Announcement

Cyber-security specialist Tesserent Limited (ASX:TNT) has appointed Kurt Hansen as Global Head of Sales. Kurt has been brought on board to grow Tesserent’s local and international Security-as-a-Service business. Kurt, whose career in the IT industry spans more than 20 years, has a proven track record of transforming sales teams and delivering significant business growth.

Most recently Kurt was Regional Managing Director for Check Point Software Technologies, where he was responsible for Cyber Security Sales and Services in Australia and New Zealand. Kurt was instrumental in building a high-performing sales culture within Check Point’s impressive growth in Australia & New Zealand.

To view the full announcement, please click on the button below.

GlaxoSmithKline Extends Service Agreement with MedAdvisor

16th June 2016, ASX Announcement

Highlights

  • GlaxoSmithKline (GSK) Australia extends its services agreement with MedAdvisor for a further 12 months.
  • GSK will continue utilising MedAdvisor’s medication management platform to provide relevant information for patients prescribed three medicines within GSK Australia’s respiratory portfolio.
  • Agreement will generate Patient Engagement Program (PEP), formerly knows as Medication Training and Adherence Campaigns (MTAC), revenue for MedAdvisor.
  • Allows GKS Australia to leverage the MedAdvisor platform to support patients on the safe and effective use of these medicines.

MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that the Australian arm of leading global pharmaceutical company, GlaxoSmithKline Australia Pty (GSK) has extended its services agreement with MedAdvisor for a further 12 months.

Under the agreement, GSK Australia will continue providing tailored messages to patients prescribed medicines with GSK Australia’s respiratory portfolio.

To view the full announcement, please click on the button below.

Take a Look at Legado Partners’ Pipeline

Today’s featured business is ‘Project Solution’.  A fast emerging niche service company.

Project Solution is an award winning business perfectly positioned to take advantage of the digital office revolution involving the majority of businesses from all industries.

This award winning business’ management team have been in place in excess of 10 years and have been heavily involved in planning and running the business historically.

Their customer base if highly diversified covering small and large private and public sector organisations.

Legado is highly impressed by the management team and the opportunities this company has created to date and their future outlook.

The Breakdown

Industry – Business Services
Revenue – $15 million (2015)
EBITDA – $2.5 million (2015)
Headline Price – $8 million

BioDiem Non-Renounceable Pro-Rata Entitlement Offer

14th June 2016, BioDiem

BioDiem announces a pro rata nonrenounceable Entitlement Offer to raise up to approximately $1,250,000 (before costs).

Funds will be used to progress the next phase of commercialization of BioDiem’s influenza vaccine (LAIV) licensing business; and its antimicrobial, BDM-I, in development for the treatment of infectious diseases through BioDiem’s subsidiary, Opal Biosciences Limited (“Opal Biosciences”).  BioDiem has commercial parties interested in new and extended LAIV licences.  BioDiem receives upfront, milestone and royalty payments from new licences to its technology.

A copy of the BioDiem Prospectus and a personalised entitlement and acceptance form, including BPay details will be mailed to shareholders.

The Prospectus is available on the BioDiem website.

DeClout Propose Increase in Shareholding in an Associated Company to a Subsidiary

14th June 2016 , DeClout Limited

The board of directors (the “Board” or “Directors”) of DeClout Limited (the “Company”, and together with its subsidiaries, the “Group”) refers to the Company’s announcement dated 4 June 2016 on the proposed increase in shareholding in an associated company to a subsidiary (“First Announcement”). Unless otherwise defined herein, all capitalised terms shall have the same meanings ascribed to them in the First Announcement.

As set out in paragraph 11 of the First Announcement, as the relative figured computed based on Rule 1006(b) of the Catalist Rules may not be meaningful for the Proposed Acquisition and the Proposed Subscription, the Sponsor will, on behalf of the Company, consult with the SGX-TX on the necessity to obtain the Company’s shareholders’ approval for the Proposal Acquisition and the Proposed Subscription.

To view the full article, please click on the button below.

BIG Un Ltd Continue Strong Growth with $1m in Cash Receipts

15th June 2016, ASX Announcement

Highlights

  • Strong growth has continued in the current June quarter with $1 million in cash receipts expected from sales achieved during the two months to the end of May
  • Cash receipts from customers are expected to increase by at least 27% on the March quarter reaching a minimum of $1.5 million for the June quarter representing an annualised run rate of in excess of $6 million
  • Cash receipts from customers expected to exceed $3.7 million for the Financial Year 15/16
  • Ongoing growth demonstrates the high level of demand for the product and the success of sales initiatives
  • Growth expected to continue into the September quarter as the Company continues to invest in its technology  and global growth strategy

Big Un Limited (ASX: BIG, ‘BRTV’ or ‘the Company’) today provides an update on trading performance for the current June quarter.

The Company is pleased to report it has continued strong growth in the June quarter with $1 million in cash receipts expected from sales achieved during the two months to the end of May 2016.

To view the full announcement, please click on the button below.

Alcidion Develops Data Acquisition Technology for NEDA

15th June 2016, ASX Announcement

Highlights:

  • Data Acquisition Technology developed for National Echo Database Australia.
  • Collates several million echocardiograms into national database.

Alcidion Group Limited (ASX: ALC) has developed a new technology in partnership with the National Echocardiography Database of Australia (NEDA). The technology extracts, normalises and amalgamates data from Echocardiography (“Echo”) studies performed around Australia into a single, centralised cloud hosted database server. NEDA is headed up by internationally renowned cardiologist, Professor David Playford and the CEO of the Pulmonary Hypertension Society Australia and New Zealand Inc, Associate Professor Geoff Strange.

To view the full announcement, please click on the button below.

YuuZoo and Etisalat Sign an Agreement to Launches New E-Commerce Platform in Nigeria

13th June 2016, YuuZoo

  • YuuZoo and Etisalat, the largest mobile operator in Africa and the Middle East, have signed a new agreement that launches a new e-commerce platform in Nigeria, Africa’s biggest market
  • Move gives YuuZoo prime access to the booming e-commerce market in Nigeria, with a focus on the huge SME market
  • Partnership with the largest telco in Africa and the Middle East opens up the potential for further expansion in the region
  • Concurrently, YuuZoo has bought over all rights for Etisalat from its franchisee, who signed an earlier contract with Etisalat in 2014

Singapore-listed YuuZoo Corporation Limited (“YuuZoo SGX: AFC) has, in Africa’s largest market Nigeria, signed an agreement with Etisalat, the largest mobile operator in Africa and the Middle East, for the launch of a powerful new e-commerce platform targeting the country’s booming small and medium-sized enterprises (“SME”)  market.

The partnership between Etisalat and YuuZoo provides Nigerian SMEs with a broad-based new e-commerce platform, www.smearena.com.ng (“SME Arena”). The platform, built and managed by YuuZoo and marketed in Nigeria by Etisalat, is a portal through which SME’s can market and sell their products and services.

To view the full announcement, please click on the button below.

SUDA Announces New Analyst Report

14th June 2016, ASX Announcement

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug deliver, today announces that Alpha Deal Group, LLC has issued a new investment report on SUDA. The reports from Alpha Deal Group were commissioned by SUDA and are available on the Company’s website via the following link:

www.sudaltd.com.au/index.php/analyst-reports

Alpha Deal Group is a US-based buy-side advisory and equity intelligence firm focused on identifying uniquely positioned, event-driven, equity growth opportunities for asset managers, hedge funds and private equity firms on several global institutional platforms that include Thomson Reuters Eikon, S&P Capital IQ and FactSet.

To view the full announcement, please click on the button below.

YPB Receives Fourth New Order in Four Months from Affyrmx Joint Venture

9th June 2016, ASX Announcement

YPB Group Limited (ASX: YPB) has secured its first high security vital record document order from one of Mexico’s largest states. With the initial supply of 395,000 documents this is an important step towards the goal of securing all of the state’s annual supply of an estimated 5 million documents.

As one of the most populous of the 32 federated states of Mexico, this is a particularly significant  target for YPB’s Government vital documents business.

This order is no the fourth state in four months to entrust the supply of its critical vital record documents to YPB’s joint venture (JV) with Affyrmx LLC. The early successes of the JV, subsequent to its February 2016 launch, encourage optimism that it can achieve the ambition of becoming the leading supplier of a comprehensive range of Government vital documents to the Federal and State Governments of Mexico and its 130 million citizens.

To view the full announcement, please click on the button below.

Altech Secures Another Quality Cornerstone Investor

9th June 2016, ASX Announcement

 Highlights:

  • Altech secures Malaysian publicly listed MAA Group Berhand (MAAG) as cornerstone investor
  • MAAG is an insurance, investment, credit and finance group with total assets of RM1.45 billion
  • Placement of $1.0 million of March 2016 shortfall shares
  • A total of ~$5.0 million raised since March 2016

Altech Chemicals Limited (Altech / the Company) (ASX: ATC) is pleased to announce that it has secured another quality cornerstone investor, MAA Group Berhad (MAAG), which will subscribe to $1.0 million of Altech shares (March 2016 placement shares).

To view the full announcement, please click on the button below.

 

Martin Aircraft Company Newsletter June 2016; P12.3 and P12.4 Jetpacks Receive Experimental Certification

9th June 2016, ASX Announcement

Welcome to our June 2016 Newsletter.

This month we’re excited to announce that our prototype P12.3 and P12.4 aircraft have achieved experimental status. For our enthusiasts we’ve included a graphic on basic Jetpack assembly, excluding sub-assemblies, and we introduce two key members of our team as we move to production and delivery.

Martin Aircraft P12.3 and P12.4 Jetpacks Receive Experimental  Certification 

We have previously announced that Martin Aircraft Company had made a decision to move away from our original microlight certification pathway towards type certification the Jetpack. Type certifying the Jetpack consists of three main stages

  • Experimental
  • Restricted
  • Full Type Certification

To view the full announcement, please click on the button below.

Proteomics PromarkerD Development Advances in China

14th June 2016, ASX Announcement

Highlights:

  • PILL and its Chinese partner Newsummit Biopharma have secured funding towards development for an In vitro Diagnostic (IVD) kit for PromarkerD in China.
  • Chinese patent granted for PromarkerD as a predictive and diagnostic test for diabetic kidney disease.
  •  Initial tranche of funding under the PILL-NSB agreement will  support the first stage of PromarkerD IVD kit manufacture.
  • China is a key global market for PILL – WHO estimates 120m Chinese have diabetes and are at risk of kidney disease.

Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce significant advances towards commercialisation of PromarkerD as an In vitrro Diagnostic (IVD) test in China, with the grant of a key patent and funds secured to initiate kit manufacture.

To view the full announcement, please click on the button below.

OrionVM Partners with NEXTDC

8th June 2016, ARN By Holly Morgan

Australian Infrastructure-a-as-Service (IaaS) provider, OrionVM, has partnered with NEXTDC to expand the reach of its hyper-converged IaaS platform through NEXTDC’s national Datacentre network.

The platform is currently used by state and federal government departments such as the NSW Department of Industry as well as large-scale telcos.

According to OrionVM chief operating officer, Matt Ding, the company is currently navigating a period of high growth and wants to double the size of the business in 2017.

To view the full article, please click on the button below.

Altech Chemicals Chief Financial Officer Interviewed on Canary Networks

8th June 2016, ASX Announcement

Altech Chemicals Limited (Altech/the Company) (ASX:ATC) advises that an interview with chief financial officer and company secretary, MR Shane Volk was recently conducted by Canary Networks and is now available for viewing.

In the interview Mr Volk discusses the Company’s proposed Malaysian high purity alumina project, project financing and the market opportunities for Altech’s 99.99% high purity alumina product in generla.

To view the interview, please click on the button below.

To view the full announcement, please click on the button below.

Invitation to Legado’s Private Capital Investments Early Stage Comment Forum

Legado invites you to attend an early comment forum with current and prospective investors.

This session is to provide you with an opportunity to gain insight into specific deals in our pipeline and share with us your perspective on the opportunities in front of us.

There are some very good private businesses for sale in Australia where you can buy them at much lower price than listed shares or large corporates. There are also some very good management teams who run these businesses, who need cash and resources to help with the transition for the current owner.

Is Legado right for you? 

If you have investable funds of $500,000 or more, you invest for the long term, you seek outstanding returns of 20%+, and you have an understanding or an appreciation of business then you may be a good fit. Please contact our office for further information or to understand the investment options that Legado offers.

Event Details:

Canberra

Tuesday 21 June 2016,
4:00PM and
Wednesday 20 July 2016,
4:00PM
Legado Office, Level 1,
113 Canberra Ave, Griffith.
Register Here.

Sydney

Tuesday 14 June 2016,
4:00PM
The Westin, 1 Martin Place,
Sydney
Register Here.

Melbourne

Wednesday 15 June 2016,
4:00PM
The Westin, 205 Collins Street,
Melbourne
Register Here.

Actinogen Receives US FDA Feedback to Enhance Alzheimers Study

8th June 2016, ASX Announcement

Highlights:

  • Productive interaction with the US Food and Drug Administration (FDA)
  • Protocol enhancement will strengthen the value of the Phase II trial
  • Harmonising Australian and UK trial with US FDA increases potential global value
  • Fits into broader US strategy of medical publications slated for 2H16 and US investor campaign in 2H16

Actinogen Medical Limited (Actinogen Medical, ASX: ACW) is pleased to announce productive progress with the US Food and Drug Administration (FDA) to enhance the safety profile of XanADu, the Phrase II trial of its lead Alzheimer’s drug candidate, Xanamem™.

Good progress has been made with the Actinogen Medical team towards securing final US FDA approval under an Investigational New Drug (IND) for the Phase II study.

To view the full announcement, please click on the button below.

Booodl CEO Interviewed on Sky News

8th June 2016, YouTube

Booodl went live on Sky News last week. It was a great opportunity to spread the Booodl message far and wide, and educate about Store Discovery Optimisation. The team truly believes SDO is the key to helping physical retailers defend against the impending Amazon crush, and they are taking it upon themselves to make sure they’re up to speed!

To watch the interview, please click on the button below.

Air Volution CEO Interview

Air Volution Ltd (AVL) is an Australian public company focussed on the manufacture and sale of a range of revolutionary, affordable, highly efficient and environmentally friendly air powered motor vehicles that are being developed in France by Motor Development International (MDI). Air Volution holds exclusive rights to MDI vehicle manufacturing factories in Australia, New Zealand and the Pacific region. The technologies designed and built by MDI have the potential to create valuable economic and environmental sustainability.

The core product is a compressed air engine that has multiple applications in the transport and energy arenas. The engine is also reversible and recompresses air into a built in carbon fibre storage tank. The lightweight engine offers a pathway towards freedom from fossil fuel reliance. The Company requires funding to establish the first of a suite of factories required to manufacture the initial range of MDI urban transport vehicles.

Please listen to John Mennega, CEO of Air Volution below.

BIG Un Limited Rights Issue Closes Oversubscribed Raising $2.64m

7th June 2016, ASX Announcement

  •  Successful completion of 1 for 4 rights issue closing significantly oversubscribed raising $2.64 million
  • Oversubscription reflects the strong support and interest from new and existing shareholders, which included participation from board and management
  • Fund to accelerate global marketing roll-out and major enhancement of interactive video platform to further progress SaaS strategy and incraese subscription revenue

BIG Un Limited (ASX: BIG or ‘the Company’) is pleased to announce its non-renounceable rights issue, announced 10 May 2016, has closed significantly oversubscribed and raised a total of $2,638,117 (before costs).

The 1 for 4 rights issue consisted of a free attaching option for every two  new shares subscribed for. As a result, a total of 21,984, 307 new shares and 10,992,154 new options with an exercise price of $0.25 and expiry on 31 December 2017 were issued.

To view the full announcement, please click on the button below.

Charter Hall Prepares IPO of Long WALE REIT

7th June 2016, ASX Announcement

Charter Hall Group (ASX: CHC) (Charter Hall or the Group) today announces that it is preparing to list on the ASX a new real estate investment trust, Charter Hall Long WALE REIT (Long WALE REIT or the REIT). It is intended that the REIT will be comprised of a geographically diversified portfolio of industrial, office and hospitality assets with a total value of greater than $1 billion and a weighted average lease expiry (WALE) in excess of 12 years.

Charter Hall’s Managing Director and Group CEO, David Harrison said: Given recent volatility across global equity and commodity markets, we expect quality property with secure cash flows to remain highly attractive to institutional and retail investors. The creation of Long WALE REIT is a further continuation of the Group’s strategy and we look forward to presenting investors with the opportunity during 2016″.

To view the full announcement, please click on the button below.

SportsHero And YuuZoo Partnership Kicks Off, Bringing Fantasy Sports To Over 118 Million Users Across 164 Countries

6th June 2016, YuuZoo

Highlights:

  • SportsHero is Asia’s first real-time fantasy sports app; it secured US$2.4 million in Series A funding and is accelerating plans to list on the Australian Securities Exchange (ASX)
  • YuuZoo is the first social media company to be listed on the Singapore Exchange (SGX); it was founded and is helmed by former Regional Head of Nokia Asia-Pacific, Thomas Zilliacus
  • Extends the sporting experience for fans and gamers to beyond the stadium bleachers, television screen and projectors to their mobile devices
  • Partnership taps a global e-sports market expected to surpass US$1.1 billion in revenues by 2019

SportsHero (SportsHero.mobi), Asia’s first real-time fantasy sports app and social prediction platform, has partnered with Singapore-based YuuZoo Corp (“YuuZoo“, SGX: AFC), one of the world’s fastest growing third generation social e-commerce networks. The two companies will jointly bring SportsHero to YuuZoo’s network of over 118 million consumers across 164 countries. YuuZoo’s users will leverage on SportsHero’s highly engaging, gamified social sports prediction platform, which includes daily, weekly, and monthly prizes – a new gaming experience for their registered users. At launch, daily average user engagement on SportsHero exceeds 10 minutes.

SportsHero is formed under Singapore’s MyHero, which also owns and develops TradeHero (TradeHero.mobi). TradeHero has been ranked the world’s #1 finance app in over 91 countries with over 8 million users (App Annie).

To view the full announcement, please click on the button below.

BPS Extends into China with $2m Distribution Agreement

6th June 2016, ASX Announcement

Highlights:

BPS to facilitate the sale and distribution of Morlife Australian functional foods in China

BPS to earn a merchant transaction and marketing fee on all goods sold

Leading financial technology platform provider BPS Technology Limited (ASX: BPS, “the Company”) is pleased to announce it has executed a Merchant Agreement to facilitate the selling and distribution of Morlife health products into China’s market on Alibaba’s 1688.com, via its Master Merchant Agreement with SmartTrans Holdings Limited (ASX: SMA).

Morlife, Australia’s leading innovator in functional foods, is the first of BPS’ merchants to sell  through Alibaba’s sales channel via the landmark agreement BPS announced on 18 May 2016. The company is planning further arrangements for more BPS merchants to take advantage of this new sales channel, initially in the Health and Superfoods, Property, Travel and Education categories.

To view the full announcement, please click on the button below.

Peppermint Solutions for Mobile Payments Presentation

6th June 2016, ASX Announcement

Vision Statement:

Our aim is to provide mobile payments, money services and remittances to anyone, anywhere in the world, especially those not currently linked to traditional banks.

Company Snapshot:

ASX listed Fintech company targeting the global mobile payments sector

Listed on the ASX in December 2015

Founded March 2015

What we do;

  • Operate an established and commercially deployed mobile phone banking, payments and remittance platform in the Philippines
  • Deliver mobile payment services to facilitate financial inclusion and consumer convenience
  • Improve business efficiency and derive revenue for commercial clients and agent networks

To view the full Presentation, please click on the button below.

Investor Research Report on Martin Aircraft Available

Stockmarket researcher Australia Small Cap Investigator recently released a report on former Axstra client Martin Aircraft (ASX:MJP) - download report here.

It is very comprehensive and covers some interesting points about MJP, uses for the Jetpack and potential future value scenarios.

If you are a shareholder of MJP, or interested in the stock, I encourage you to read this in full as it explains why the company has so much upside potential as it enters production (and revenue) for the first time.

Here are some quotes from the report:

  • The personal jetpack could be the ‘must have’ toy for billionaires in 2017
  • As first movers in an industry that they’re actually creating, they could see emergency personnel all over the world using their products for rapid response times
  • And if they can ramp up production, the share price could skyrocket…much like their customers
  • If they make and sell 1,000 jetpacks, they’d be looking at   revenues of $250 million. A P/E of 40 would see the market cap closer to $1 billion — that would be a 449% gain
  • The company also has no debt, $36 million in the bank and is on the cusp of delivering jetpacks to customers. At just 55.5 cents a share, the time to buy up Martin Aircraft stock is now!

SUDA June 2016 Investor Update; Negotiations to Licence Oro-Muscal Sprays Continue, Expansion of Business Development in China, ChinaBio Conference

7th June 2016, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-muscal drug delivery, notes the weakness in its share price and today provides an update on its activities. Negotiations with pharmaceutical companies to licence SUDA’s first-in-class oro-muscal sprays continue to advance towards final agreements. These discussions span various products and territories. Subject to successful contract negations, SUDA could finalise several agreements in the next few weeks and months.

SUDA has recently expanded its business development outreach in China and met with over 20 Chinese pharmaceutical companies at the ChinaBio conference in Suzhou on 18-19 May 2016. Some of these meetings have already advanced to full due diligence and discussions of terms.

To view the full announcement, please click on the button below.

Aeeris Investor Presentation at the Singapore Capital Expo & Small Cap Showcase June 2016

6th June 2016, ASX Announcement

Aeeris Overview

Aeeris Limited (ASX: AER) is an ASX listed geospatial data technology business focused on providing enterprise and government customers with information to managing risks and protect their people and assets from hazards and damage.

The Company was listed on the ASX in April 2015 via an IPO, following a successful equity capital raise of $3.5 million.

Aeeris is experiencing rapid growth in 2016 following the application of new resources to drive sales, customer acquisition, technology development, new products and services and global expansion opportunities.

To view the full Presentation, please click on the button below.

Leaf Resources Placement Raises $795,000

6th June 2016, ASX Announcement

Leaf Resources would like to advise that they have received commitments, principally through Lodge Partners from sophisticated investors for a placement of 7,250,00 ordinary shares at an issue price of $0.10 as well as a conversion of 700,00 options exercisable at $0.10 thereby raising a total of $795,000.

The placement price of $0.10 was the closest market price at the close of business on Wednesday 1st June 2016, when the company suspended its shares.

In addition to the funds from the placement, the company is expecting to receive a total of over $650,00 from Joint Venture research fees, the Export Market Development Grant program and the R & D Tax Rebate in the near future.

To view the full announcement, please click on the button below.

Long Pipes Complete Capital Raise for $575K

Long Pipes have completed the capital raise for $575K this week on a con note for 15 cents.  Long Pipes are now working on the placement of funds for 15 cents for $1M to be completed immediately.  They have made a presentation at WI in Hong Kong that has resulted in a lot of interest and expect that the $1M will be filled promptly.

ABOUT LONG PIPES 

Long Pipes has developed, demonstrated and installed the Fluid Highway™ the “World’s first” continuous composite pipe made in the field without a joint for 1km or 1,000kms. It is the lowest cost, lightest, strongest, lowest CO2, lowest environmental impact, lowest labour and fastest to install fibre composite pipe globally.  The Fluid Highway ™ is unique it is tough, strong, flexible, designed to withstand extreme corrosion, erosion, temperature variations and pressures up to 130 Bar so far.

The Fluid Highway™ is globally unique; with strong IP, a disruptive technology in the disrupted market of fluid transportation, to replace steel, high density polyethylene and fibreglass for oil, gas, water slurry and hydro transportation. We have first contract and numerous other contracts in discussion with an addressable market of US$12-15B in the next 5 years.

Z-Filter to Improve the Standard of Living of Millions of Chinese

Z-Filter have just spent the last week in Beijing in discussions on the clean-up of China for water air and power and have placed a first proposal. This is massive and Z-Filter is perfectly suited to this task.

Z-Filter had a very worthwhile series of discussions with potential equity investors and strategic partners on the introduction of Z-Filter into the Chinese market.

As part of this they will receive $500K next week under a convertible note at 12 to 15 cents per share.

The Chinese market is great and the benefits that the Z-Filter technology can bring to the Chinese market/environment is immense and will improve the standard of living of millions of Chinese, with 12 billion and then Y64 billion overall attaching to it.

If the tests work in China Z-Filter will expand into India and the rest of Asia.

ABOUT Z-FILTER 

Filtration, separation, drying are the primary processes for the production of almost everything. Z-Filter filters using gravity, separates with just vibration and dries without heat or pressure.

These technologies are patented, low cost, simple, energy efficient and high volume. The results are dirty water, is cleaned; the solid waste separated and compacted:- for industrial, diary, piggery.

Great wealth can be produced from taking wastes; dirty, iron ore or coal cleaning it to produce high grade, clean, dry, ores for steel. The first product is the Z-300A filter with first deliveries to Europe.

Catcha Group Partner Bulletin June 2016; Wild Digital 2016, iflix Launch in Indonesia, Ensogo Adopts B2C Marketplace Model

SOUTHEAST ASIA’S LEADING INTERNET LEADERS TAKE THE STAGE AT WILD DIGITAL

Here are just some of the speakers who will be at Wild Digital. Click here to see the full list.

Don’t miss your chance to hear from the region’s Internet leaders – get your ticket here

MALAYSIA’S IFLIX GAINING SCREEN TIME ACROSS SOUTHEAST ASIA

Nikkei Asian Review
Malaysia’s iflix is aiming to be the leading online video streaming service in emerging markets and it has already gathered more than a milllion subscribers across Southeast Asia.
Read more

IN THE NEWS

iflix: Internet television service to launch on Indonesian shores in June
Asian correspondent · Read More

iflix is one year old, here’s to more great things to come
Vernonchan.com · Read More

Malaysia’s iflix marks first birthday
Channel News Asia · Read More

iCar Asia appoints former iMoney exec Harry Antarakis as CMO
Digital News Asia · Read More

Ensogo adopts B2C marketplace model
Digital News Asia · Read More

More Catcha Group coverage here

SUDA Update on HC Berlin Pharma

3rd June 2016, ASX Announcement

SUDA Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it has received a Statement of Claim in relation to a lawsuit between the Company and HC Berlin Pharma AG (in liquidation).

A review by our legal advisors in Germany has identified that the Statement of Claim contains assertions that are not based on fact, therefore based on our legal advice, the Directors of SUDA believe that the claim is without significant merit and will be vigorously defended.

In 2008, HC Berlin Pharma entered into an agreement with SUDA (then Eastland Medical Systems Ltd) for certain manufacturing rights. The licence granted to HC Berlin Pharma was subject of an in-kind capital contribution and SUDA was issued with shares in the capital of HC Berlin Pharma in exchange for these rights.

To view the full announcement, please click on the button below.

Alcidion’s Intelligent Cardiovascular Information System (iCVIS) to be Delivered to Sunshine Coast University Hospital Through FUJIFILM

3rd June 2016, ASX Announcement

Highlights: 

  • Strengthening of the commercialisation of iCVIS through FUJIFILM.
  • Contract to deliver iCVIS to Sunshine Cost University Hospital.
  • Cardiovascular Information System market estimated to be $USD917m by 2020.

FUJIFILM Medical Systems, a division of FUJIFILM Australia Pty Ltd (FUJIFILM), has secured a contract to deliver a leading edge intelligent cardiovascular Information System (iCVIS) to the Sunshine Coast University Hospital in Queensland, Australia. iCVIS was developed by Alcidion for FUJIFILM and is built upon the Miya platform to address clinical rick, workflow and logistic issues that are encountered in cardiology labs. The terms of the transaction remain commercial-in-confidence.

To view the full announcement, please click on the button below.

Altech Generates Interest at International Battery Fair

3rd June 2016, ASX Announcement

Highlights:

  • Interest generated by Altech as emerging HPA supplier for lithium-ion battery separators
  • Electric  vehicle manufacturers are demanding lithium-ion batteries with 99.99% HPA-coated separators
  • HPA-coated separators improve battery safety and stability
  • HPA supplied to China is priced in the range of US$27 to US$30 per kilogram
  • Altech’s bankable feasibility study HPA price assumption is US$23 per kilogram

Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to advise that it generated strong interest as an emerging high purity alumina (HPA) producer during its recent attendance at the 12th China International Battery Fair (CIBF) in Shenzen, China (May 24-26, 2016). The CIBF is held every two years and is significant event for the lithium-ion battery industry.

To view the full announcement, please click on the button below.

Leaf Resources Investor Update: Australian Patent Lodged & Edision Research Report

2nd June 2016

Highlights of Australian Patent Lodged:
  • Provisional Australian patent application lodged which details a method for extracting silica from organic material including agricultural waste/biomass;
  • Some agricultural wastes, especially rice husk, contain an attractive source of silica;
  • Rice husk after silica extraction is potentially a new, large and economical biomass resource for Leaf Resources’ GlycellTM process;
  • Further testing is required to determine if the extracted silica can be used in microchip manufacturing – an industry estimated to be worth over US$300 billion a year;
  • Preliminary testing shows the GlycellTM process works well with rice husk and straw as an input.

To view the full article, please click on the button below.

Edision Research Report: Value Creation through GlycellTM Commercialisation

Leaf Resources (ASX:LER) is taking steps to commercialise its GlycellTM technology. This produces sugars from biomass for processing to high-value bio chemicals at a much lower cost than alternative technologies, providing the foundation for new projects based on ‘advantaged’ biomass. GlycellTM has the potential to transform the economics of global renewable chemicals.

To view the full article, please click on the button below.

Analyticas’ AutoStart Burette Listed Through Queensland Health Tender

3rd June 2016, ASX Announcement

Analytica (ASX: ALT) is pleased to announce that the AutoStart® infusion system product has been listed on the Queensland Health purchasing schedule. The product was listed by Medical Australia Ltd (ASX: MLA) the Australian sponsor of the device under their Tuta FirstFlow® brand name.

Inclusion in the schedule is a pre-requisite for all public Queensland health facilities to purchase medical devices and other health products. The listing will be reviewed in 2019.

Chairman Dr Michael Monsour said “The listing is another milestone achieved in the commercialisation of the AutoStart infusion system. It allows the product to be purchased by any Queensland Health hospital or health clinic and we aim to list in other states as tenders fall due.”

To view the full announcement, please click on the button below.

YPB Group Ltd to Protect NZ Exports to China

2nd June 2016, Proactive Investors

YPB Group Ltd (ASX:YPB) will look to protect exports of New Zealand products to China under a new 3-year, $1.2 million supply contract signed with Comtech Solution.

The anti-counterfeiting technology provider YPB is part of brand protection solution that aims to combat the estimated $1.7 trillion global counterfeit market.

The New Zealand contract includes brand protection for Comtech’s clients which include one of New Zealand’s top fruit exporters, premium New Zealand Honey and New Zealand produced milk powders.

YPB will supply its anti-counterfeit technologies including secure QR codes containing forensic covert tracer, T2 scanners and YPB’s Brand Reporter platform.

YPB is building a franchise in anti-counterfeit, customer engagement and Government vital documents solutions.

To view the full article, please click on the button below.

CropLogic Secures New Licence for Global Growth

2nd June 2016, Scoop

Precision agriculture firm CropLogic has signed an exclusive agreement with the New Zealand Institute of Plant & Food Research to expand the marketing of its patented technology to corn, wheat, soybean and cotton farmers in the United States.

The technology — developed over 30 years out of Plant & Food Research, a New Zealand Crown Research Institute, and guided and shaped for international markets by IP investor Powerhouse Ventures — enables growers using the firm’s predictive modelling systems to pinpoint the best times to apply nutrients and to conserve precious water for maximum plant yields.

Under an earlier agreement relating to potatoes, CropLogic has successfully created a predictive decision support system that has attracted some of the world’s top potato growers and processors in the most demanding regions in the world. Initial trials of the technology in the US, NZ, China, and Australia have indicated yield improvements of over 6% and substantial improvements in crop profitability. For a top-tier Idaho potato farmer that can amount to a 90% profit improvement.

To view the full article, please click on the button below.

Mentor Education Builds Out Board

1st June 2016, Indepenent Financial Adviser

One of Australia’s largest privately-owned financial services training companies, Mentor Education, has appointed a corporate strategist and educator to chair the group’s 10-person academic board.

David Lamond has had an international career as a senior adviser on corporate strategy, human resource management and executive development.

Mentor Education’s chairman, Jim Taggart, said: “Dr Lamond is joining a fantastic organisation aiming to deliver relevant education for financial planners who are keen to undertake the next generation of quality courses and degrees.”

Dr Lamond was the inaugural chair of Australia’s Financial Planning Education Council between 2011 and 2013. During his time at the council, he implemented the Australian higher education curriculum and accreditation framework for financial planning.

To view the full article, please click on the button below.

Leaf Resources Lodge Australian Patent for Method for Extracting Silica

2nd June 2016, ASX Announcement

Highlights:

  • Provisional Australian patent application lodged which details a method for extracting silica from organic material including agricultural waste/biomass;
  • Some agricultural wastes, especially rice husk, contain an attractive source of silica
  • Rice husk after silica extraction is potentially a new, large and economical biomass resource for Leaf Resources’ Glycell™  process
  • Further testing is required to determine if the extracted silica can be used in microchip manufacturing – an industry estimated to be worth over US$300 billion a year;
  • Preliminary testing shows the Glycell™process works well with rice husk and straw as an input

Leaf Resources Ltd (ASX:LER), the ‘Company’) is pleased to advise that it has lodged an Australia provisional patent application (No. 2016901959) entitled “Method for extracting Silica”, which details a method for extrating silica from organic material, includig plant waste/biomass.

To view the full announcement, please click on the button below.

QBiotics Presents its Veterinary Cancer Compound

1st June 2016, Life Scientist

Australian life sciences company QBiotics outlined the latest clinical developments in its cancer compound, EBC-46, to an audience of veterinary cancer experts last week.

Speaking at The World Veterinary Cancer Congress in Brazil, QBiotics CEO Dr Victoria Gordon and Chief Veterinary Officer Dr Stewart Lowden showcased the latest clinical research results from a range of studies. The trials underpin the efficacy of EBC-46 as an intratumoral treatment for cutaneous and subcutaneous mast cell tumours and soft tissue sarcomas in dogs.

EBC-46 is a natural product isolated from the seed of Australian rainforest shrub Fontainea picrosperma. A ready-to-use injectable solution, the drug works by initiating tumour necrosis directly and by tumour blood vessel destruction, followed by rapid wound healing.

“EBC-46 is a signalling molecule which turns on the animal’s own immune system to destroy the tumour,” explained Dr Gordon. “It also has the advantage of being easy to administer, causes minimal trauma to the animals during treatment and has no significant negative side effects.

“Tumour destruction is rapid [and] wounds heal without the need for intervention, such as antibiotics and lotions, and with minimal scarring.”

To view the full article, please click on the button below.

MedAdvisor Signs Strategic Agreement with Arrow Pharmaceuticals

1st June 2016, ASX Announcement

Highlights:

  • MedAdvisor has  sign a strategic agreement with Arrow Pharmaceuticals, one of Australia’s largest generic pharmaceutical manufacturers
  • Arrows Pharmaceuticals’ 35 plus strong national sales teams to promote the MedAdvisor platform to its extensive first-line customer base of over 1,100 pharmacies from June 2016
  • Strong platform validation with MedAdvisor now partnered with Australia’s two largest generic companies: Apotex and Arrow Pharmaceuticals
  • Aligns with MedAdvisor’s strategy to substantially increase its referrer and patient customer base to drive revenue and growth

MedAdvisor Limied (ASX:MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed  a binding strategic agreement with Arrow Pharmaceuticals, Australia’s second largetst generic pharmaceutical manufactures, following the announcement of its Memorandum of Understanding in March 2016.

To view the full announcement, please click on the button below.

iSentric Expands Into Myanmar & Completes Two New Deals in Indonesia

1st June 2016, ASX Announcement

Highlights:

  • Building on its success in Indonesia and Malaysia, iSentric has entered the rapidly growing Myanmar market. The company will market and distribute Digital Media Services to Myanmar’s largest telco MPT, a business with a user base of 20 million
  • Continued launch of premium media content in Indonesia with the release of “THE FREAKS” album, which is being distributed broadly by KFC stores
  • Collaboration with VONVON, a Korean internet media company that creates viral content, to market exclusive artist content, to market exclusive artist content to 70 million Indosat Ooredoo and XL subscribers, with approximately 200,000 paying subscribers to date

In line with their growth strategy, iSentric Limited (“iSentric” or “The Company”) is successfully expanding in their target South East Asian markets, benefiting from the substantial opportunities to market premium digital media content in countries with large and growing numbers of internet users.
To view the full announcement, please click on the button below.

Thinxtra is Going to Power the Future of IoT

31st May 2016, Business Insider Australia, By Josh Nicholas

The Internet of Things holds incredible promise – sensors embedded in everything from shipping pallets to cars and fridges, passing on data and making everything “smart”.

The data could be varied — temperature, location, condition and activity among them. The uses are innumerable. But for all of this potential to be realised, there has to be a way to connect it all.

A system to allow millions of little sensors to easily and cheaply network. This is the opportunity an Australian startup called Thinxtra is going after.

You can get a sense of the potential of IoT simply by looking at companies like The Yield, a Tasmanian startup bringing smart sensors to the Oyster industry and potentially saving millions in wasted time and product with precise monitoring.

In these kinds of closed environments, or at your home or office, the Internet of Things is already very powerful. You can just hook up your smart scale or thermometer to your wifi network. Instantly, your devices can talk to each other through automation services like If This Then That, or some other analytic or automation platform.

To view the full article, please click on the button below.

TFS Unaudited Results; Cash EBITDA Up to $12.1million

31st May 2016, ASX Announcement

TFS Corporation Limited (“TFS”, ASX: TFC, “the Company”), the world’s largest owner and manager of commercial Indian sandalwood plantations, today reported its unaudited results for the nine months ended 31 March 2016.

Cash EBITDA, which removes the impact of non-cash revenues and unrealised foregin exchange movements, was $12.1 million, up 16% from $10.4 million in the previous corresponding period (“pcp”, being the nine months to 31 March 2015), due mainly to higher sale of new plantations to institutional investors.

Net profit after tax of $66.2 million was down on the pcp ($81.3 million) with lower foreign exchange gains for the period compared to to the pcp resulting in a smaller gain in the fair value TFS’s owned plantations.

To view the full announcement, please click on the button below.

PANALITIX Announces Firm of NOW Roadshow for Accountant Development

24th May 2016, Business Wire

PANALITIX, the global leader of a subscription-based community for accountants and financial advisors, today announced the opportunity for accountants nationwide to grow and increase their business advisory capacities through learning at the PANALITIX 2016 Roadshow: Firm of NOW, a traveling conference program with upcoming U.S. dates throughout the summer and fall.

“Firms who have attended PANALITIX seminars in the past have had quick success, adding more than $100,000 in revenue within five months by implementing the tools and resources learned at the seminar,” said Rob Nixon, founder and CEO of PANALITIX. “Anyone involved in accounting can benefit from attending a Firm of NOW seminar.”

During the Firm of NOW roadshow, participants nationwide will have the opportunity to attend one-day seminars packed with information, tools and resources that can be used to implement immediate action plans to compel firm growth and profits and build client advisory services through keen business intelligence.

To view the full article, please click on the button below.